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A study of the causes of liver enlargement amongst black patients at King Edward VIII 
Hospital, Durban, South Africa has revealed that congestive cardiac failure (36.7%), 
amoebic liver abscess (7.1%), hepatocellular carcinoma (5.8%) and cirrhosis (5.4%) are 
the most common causes in this population. Liver biopsy was needed to determine the 
cause in 28.7% of patients studied. 
The diagnostic yield of percutaneous liver biopsy was increased by obtaining 2 or 3 con-
secutive specimens for histological examination by redirecting the biopsy needle through 
a single entry site. This benefit was achieved without an increase in morbidity or mortality. 
Fatalities and complications associated with liver biopsy were more frequent at this hospi-
tal than in hospitals in Europe, The United Kingdom and North America. The complication 
rates after percutaneous or peritoneoscopic biopsy were 2.0% and 2.3% respectively. A to-
tal of 6 deaths was recorded. The morbidity and mortality rates were not increased when 
more than one specimen was taken during percutaneous biopsy. In the majority of 
patients in whom biopsy was carried out, after-care was either non-existent or inadequate. 
The "Tru-Cut" needle was used for all percutaneous liver biopsies at King Edward VIII 
Hospital. Two techniques, including the method recommended by the manufacturer, have 
been found to be incorrect; the needle must be used correctly if an adequate biopsy 
specimen is to be obtained for histological examination and if serious complications are to 
be avoided. 
Hepatic tuberculosis was diagnosed in 9% of patients with unexplained hepatomegaly who 
were subjected to liver biopsy. This disease did not yield any consistent clinical findings. 
In addition, liver function tests were of little diagnostic value and results of hepatic imaging 
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techniques were often normal. Accordingly, a high index of suspicion is needed and liver 
biopsy is essential in patients with unexplained hepatomegaly or hepatospienomegaly, or 
pyrexia of unknown origin since biopsy provides the only means of diagnosing hepatic 
tuberculosis. 
The accuracy of both ultrasonography and scintigraphy in distinguishing between normal 
and diseased livers was low (68% and 74% respectively). These techniques performed 
better at detecting focal than diffuse liver disease; the sensitivity of ultrasonography and 
scintigraphy in focal and diffuse disease were 88% and 92%, and 27% and 54% respec-
tively. The specificity of both procedures was high for both types of liver disease (range 
91-96%). Overlap between the ultrasonographic features of amoebic liver abscess, 
hepatocellular carcinoma and metastatic carcinoma resulted in a correct final diagnosis 
being made in only 81% of patients with amoebic liver abscess, 29% with hepatocellular 
carcinoma and 43% of patients with metastatic carcinoma who had an ultrasound scan. 
Neither technique was capable of determining the cause of diffuse liver disease. There-
fore, when diffuse parenchymal liver disease is suspected, liver biopsy is needed to deter-
mine the presence and nature of the disease. In addition, liver biopsy or aspiration is 
usually required to determine the cause of focal disease in selected patients in whom 
space-occupying lesions are detected on hepatic imaging studies. 
V I 
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Background To Proposed Studies 
Until recently, medical practitioners and students in South Africa have had to obtain 
guidance in their work and study from text books that have been written in an environment 
very different from their own. This represented a significant limitation because the distribu-
tion and pattern of diseases is not uniform in different areas; certain diseases may be com-
mon in one geographical location, but be seldom seen elsewhere. Furthermore, the 
availability of resources for investigating and treating patients differs considerably between 
first and third world countries, and within developing countries. 
This void is gradually being filled by text books written by health professionals with an in-
timate knowledge of medical practice in South Africa, a favourable development which 
must continue. The practice of medicine in South Africa, and indeed, in Africa and the rest 
of the world can and should be enriched and improved by the contributions of local 
academics and health care workers. Medical schools in South Africa have an obligation 
not only to train medical practitioners who are well-equipped to care for the populations 
they serve, but also to engage in research which is relevant to the needs of their local 
communities. The continual inflow of such scientific information from these institutions 
would lead to the accumulation of data that would supplement existing knowledge, lead to 
a revision of texts written by both African and non-African authors, favourably alter estab-
lished practice and ultimately lead to an improvement in patient care in South Africa and 
throughout Africa. 
Important contributions to various aspects of liver disease have been made by a number 
of workers in South Africa. These include major breakthroughs in the diagnosis (Powell et 
al., 1965), drug therapy (Powell and Elsdon-Dew, 1972; Wilmot et al., 1958) and other 
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aspects of the management of uncomplicated and complicated amoebic liver abscess 
(Adams and MacLeod, 1977a,b; MacLeod et al., 1966) which were made in Durban, clini-
cal and laboratory investigations in Durban and Johannesburg which clarified many 
aspects of siderosis (Bothwell and Isaacson, 1962; Bothwell et al., 1965; Gillman et al., 
1957; Isaacson et al., 1961; Wainwright, 1957), and research conducted in Johannesburg 
which has yielded important information on, inter alia, aetiological, clinical and diagnostic 
aspects of hepatocellular carcinoma (Kew, 1981; Kew and Geddes, 1982; Kew and Pater-
son, 1985; Kew et al., 1979) and hepatic tuberculosis (Essop et al., 1984; Hersch, 
I964a,b). 
This project was conducted at King Edward VIII Hospital, a teaching hospital attached to 
the University of Natal Medical School, Durban, South Africa, during the period 1984-1987. 
This hospital serves the Black community of Durban and surrounding areas. In common 
with other hospitals in developing countries, the tremendous pressure on hospital beds 
and cost are important considerations when planning patient management. Accordingly, a 
diagnosis has to be made without delay so that appropriate treatment can be instituted 
promptly. In order to achieve this goal, the pattern of disease must be known and the 
most effective methods of diagnosis must be utilised. These should preferably be non-
invasive, safe and cheap; because of the risk of complications, invasive investigations 
should be reserved for those patients in whom non-invasive tests are unhelpful or are of 
limited value. 
These studies were undertaken to delineate the pattern of liver disease and to determine 
the value and limitations of non-invasive and invasive investigations in detecting the 
presence and nature of liver disease in Black patients admitted to King Edward VIII Hospi-
tal. Radionuclide and ultrasound liver imaging and liver function tests are the non-invasive 
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tests that are generally available and widely used at King Edward VIII Hospital. Liver tissue 
is obtained for histological examination during percutaneous or peritoneoscopic liver 
biopsy, or at laparotomy. 
This project was prompted by four observations. The first was that the only report on dis-
eases of the liver encountered at King Edward VIII Hospital (Adams, 1979) had a number 
of limitations. This study was retrospective in nature and involved an analysis of sum-
maries prepared by medical staff with varying levels of competence, including house of-
ficers, in one medical unit. All patients who had died were not included in the analysis be-
cause summaries were often not prepared. In addition, patients had not been investigated 
according to a predetermined protocol; histological confirmation of diagnoses would have 
been lacking in a number of cases. Furthermore, the lack of a protocol and the fact that 
the investigations currently utilized in clinical practice were not routinely available during 
the period under study (1955-1977) would make deductions on the possible role of special 
investigations in the diagnosis of focal and diffuse liver disease impossible. The second 
was that patients admitted to King Edward VIII Hospital frequently had incidental enlarge-
ment of the liver which was usually not investigated unless it produced symptoms. The 
third was that hepatic tuberculosis was very rarely considered as a possible cause of 
hepatomegaly in this hospital. The fourth was that patients with liver enlargement who 
consumed alcohol were not infrequently presumed to have alcoholic liver disease and no 
attempt was made to confirm the diagnosis. In some patients, an abnormal radionuclide 
or ultrasound liver scan, which demonstrated abnormalities consistent with diffuse liver 
disease, was accepted as proof of the diagnosis. This approach was at variance with that 
proposed by Hersch, who had stressed the need for liver biopsy in patients with un-
explained hepatomegaly since hepatic tuberculosis often occurred without clinical or 
radiological evidence of extrahepatic involvement (Hersch, 1964a,b). 
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Historical perspectives on diagnostic procedures used in this project 
Radionuclide Imaging 
Radionuclide scintigraphy has been used to study the morphology and function of the liver 
and its related structures for more than a decade (Holder and Saenger, 1975). This diag-
nostic investigation requires the administration of a radioactive pharmaceutical followed by 
measurement of gamma radiation emitted from the body. It is simple for the patient and 
involves minimal risk. Recently, radioisotope procedures have been complemented by 
other imaging investigations such as ultrasound, computed tomography, and nuclear 
magnetic resonance. These mainly demonstrate hepatic structure and anatomical 
relationships, whereas radioisotopes give images of liver function. Function may be im-
paired by either focal or diffuse disease (Ackery and Smith, 1985). 
Two types of radiopharmaceuticals are used for routine investigation: colloid preparations 
which are taken up by Kupffer cells of the hepatic sinusoids, or chemicals and dyes which 
are actively transported by hepatocytes. Liver concentration of these agents is related to 
hepatic blood flow and the capacity of the liver to extract the radiopharmaceutical from the 
circulation. To minimize the patient radiation dose, the physical half-life of the radioisotope 
label should be short (a few hours) and there should be no beta emission. Technetium-
99m is ideal in these respects, with a 6h half-life, and no beta radiation. Technetium-99m 
sulfur colloid is by far the most widely used agent for routine liver scanning and, in the ab-
sence of severe liver disease, provides excellent images of the liver and spleen with very 
little uptake by other organs (Ackery and Smith, 1985). 
Moore is credited with the first localisation study of patients using radiopharmaceuticals 
(Moore, 1948). In an attempt to assist in the diagnosis of brain disorders, Moore syn-
thesised 131l into diiodofluorescein, injected about 20 MBq (540 uCi) intravenously and 
monitored the radioactivity over regions of the head with a hand-held Geiger-Muller tube. 
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Many investigators were confined to the use of I, as this radioisotope was readily avail-
able and had been used in the therapy of thyroid disorders during and since the 1930's. 
The development of the scintillation camera was a major contribution and influence on the 
progress of radionuclide imaging (Anger, 1958). During the 1960's there was continuing 
progress in the development of radiopharmaceuticals, rectilinear scanners and gamma 
cameras. Many different radioisotopes were evaluated in terms of imaging capabilities, 
radiation dose, availability and physiological measurement. The use of technetium-99m 
was another major land-mark in the development of radionuclide imaging. In the publica-
tion by Harper and co-workers images of the human brain, thyroid and liver were shown, 
and the advantages of using technetium-99m in terms of reduced radiation dose to the 
patient were discussed (Harper et al., 1964). The 1970's was a period of consolidation in 
radionuclide imaging. Many departments of nuclear medicine and radiopharmaceutical 
manufacturers were developing techniques and radiopharmaceuticals that were based 
upon technetium-99m. The ready availability, suitable half-life and optimum photon energy 
of technetium-99m made this radionuclide convenient to use and the trend towards low 
energy photon radionuclides helped gamma camera manufacturers to relax tolerances on 
imaging equipment. This, in turn, had the benefit of providing lighter equipment that be-
came relatively more mobile, whilst reductions in the thickness of scintillators actually im-
proved the performance of most equipment. In the early 1980's, many gamma cameras 
were capable of single photon emission computed tomography and/or whole body scans 
with either single or dual detectors. Such instruments are now routinely connected on line 
to data processors which can perform a vast array of tasks related to the acquisition and 
processing of image data. The gamma camera and computer system has become both a 
routine and research orientated diagnostic imaging device. Today, most centres rely on 
the gamma camera as the main radionuclide imaging device. The rectilinear scanner no 
longer serves the requirements of radiodiagnosis and the use of multidetector systems is 
beyond the financial scope of many hospitals (Jackson, 1986). 
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Liver Imaging by Ultrasonography 
Two major technological advances have resulted in ultrasonography becoming estab-
lished as an essential and widely used imaging modality in the study of liver disease. The 
first was the development of grey-scale ultrasound in the early 1970's which resulted in the 
display of the normal liver parenchyma and, for the first time, made possible the 
demonstration of subtle focal defects as well as the recognition of diffuse parenchymal dis-
ease (Taylor et al., 1976). The second was the development of high-resolution, real-time 
(dynamic) ultrasound equipment (Taylor, 1982). 
In 1880, the Curies discovered a means to produce and detect high-frequency sound 
waves (Shirley et al., 1978). Forty years later, in the face of the threat to the Allied Powers 
by submarines during the First World War, Langevin applied to submarine detection the 
ultrasonic techniques developed by the Curies in the laboratory (Shirley et al., 1978). 
During the Second World War this system evolved into the sophisticated Sound Naviga-
tion and Ranging (SONAR) systems. The Dussik brothers were the first to describe the 
use of ultrasound for imaging in 1937 (Shirley et al., 1978). They used a transmission tech-
nique, akin to x-radiography, to produce "hyperphonograms" of the head. In 1952 John J. 
Wild, using equipment designed to train US pilots in the use of radar, showed that it was 
possible to detect tumours of the breast and brain by comparing their echo patterns with 
those of normal tissue. In the same year, Howry and Bliss developed a machine to display 
the echoes from tissue boundaries, and published two-dimensional ultrasonic tomograms 
(Shirley et al., 1978). Close co-operation between a team led by Ian Donald, Regius 
Professor of Midwifery at Glasgow University, and an engineer, Tom Brown, led to the 
production of the first two-dimensional contact scanner in 1958 (Shirley et al., 1978). 
In 1972, Kossoff described the grey-scale technique, which for the first time made it pos-
sible to image not only the large echoes from organ boundaries, but also the small ones 
from tissue infrastructure (Kossoff, 1972). This was a major technological advance. Also 
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in the early 1970's, a great deal of work was being done on finding solutions to the 
problems posed by moving structures in scans. Since it took five to ten seconds to build 
up a conventional ultrasound image, movement during the scan was a nuisance, and pat-
terns of movement could not be studied. This led to the development of real-time systems 
which were designed to produce instantaneous moving images of moving structures. This 
proved to be another major technological advance. The pioneers in the field were Somer 
and Bom (Shirley et al., 1978). 
After the advent of grey-scale ultrasonography, examination of the liver was performed 
with static-B scanners which obtained images at 1-cm intervals in both longitudinal and 
transverse planes. This procedure was time-consuming and required many adjustments 
of the scanner as well as expertise in scanning technique. In addition, certain areas of the 
liver and kidney were suboptimally visualised due to the anterior and lateral ribs. Initially, 
the resolution of real-time scanners was suboptimal compared with the images of static 
scanners, and real-time was used as an adjunct to static scanning. However, with the 
technological improvement of real-time sector scanners, resolution became either equal 
to, or better than that of the articulated arm scanners. The major drawback of real-time 
scanning was the small field-of-view and the small image size, which made orientation of 
the image difficult; however, this problem has been circumvented by the development of 
"wide" field-of-view scanners allowing larger images (Lewis, 1984). With ultrasonography, 
information about the entire abdomen may be obtained at one examination. 
Liver Biopsy 
Percutaneous needle biopsy of the liver is a useful diagnostic procedure for which a 
variety of techniques is employed. However, although it had first been used before the 
turn of the century, it did not become firmly established in clinical practice until the 1940's. 
Paul Erlich is credited with the first biopsy (Sherlock, 1985). This was carried out during a 
study of the glycogen content of the diabetic liver in 1883. This procedure was used again 
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by Lucatello in 1895 for the diagnosis of tropical liver abscess, and in 1907 by Schupfer for 
the diagnosis of cirrhosis and hepatic tumours (Sherlock, 1985). However, it gained ac-
ceptance only in the 1930's, and was used frequently during the Second World War to in-
vestigate military personnel suffering from viral hepatitis (Dible et al., 1943; Iversen and 
Roholm, 1939; Sherlock, 1985). The original needles consisted of a trocar and cannula 
with a bore of up to 3mm. Not long afterwards, it became evident that the incidence of 
haemorrhage could be reduced by decreasing the size of the bore (Knauer, 1978), and 
that safety was also adversely affected by the slow speed of the procedure. The introduc-
tion of the "one-second" method in 1958 was a major advance (Menghini, 1958). The Men-
ghini needle permits the application of suction through a syringe attached to a needle hub. 
The tip of the needle is oblique and slightly convex towards the outside. This results in an 
excellent cut of the biopsy specimen without any need to rotate the needle. The other 
needle that is commonly used is the "Tru-Cut" needle, the disposable derivative of the 
Vim-Silverman needle. This needle uses a different principle - a trocar and cannula are in-
troduced into the liver and a core of tissue is severed within the cannula without suction 
(Hegarty and Williams, 1984). 
Peritoneoscopy is important in evaluating patients with liver disease because macroscopic 
and histological diagnosis of intra-abdominal disease can be made using this technique. 
During the procedure both the liver and peritoneum can be visualised and biopsied (under 
direct vision). The first attempts at visual examination of the peritoneal cavity without a 
large incision were reported in 1901 by Ott, who used a speculum and head mirror (Walker 
et al., 1943). Kelling was apparently the first to attempt such a procedure with an instru-
ment which carried its own source of illumination, viz. the Nitze cystoscope, which was a 
new invention. He employed a pneumoperitoneum, but his work at that time (1901) was 
only experimental and was carried out on dogs. Nine years later, he described its use in 
two human patients, and again after the last war, he wrote favourably on the subject 
(Walker et al., 1943). Jacobaeus, the pioneer of thoracoscopy, was probably the first to 
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employ this type of instrument in the human patient, for he reported, in the same year as 
Kelling, three patients with ascites whom he examined in this manner (Walker et al., 1943). 
Kalk designed the instrument that formed the basis of the present day peritoneoscopes 
(Kalk, 1929). However, it was not until Ruddock devised a special instrument with a built-in 
biopsy facility that further progress was made and the safety of the procedure satisfactorily 
demonstrated (Ruddock, 1934,1937). Nonetheless, the procedure remained unpopular in 
the English speaking countries until about 30 years ago. 
Liver Function Tests 
The term "liver function tests" is usually given to a group of biochemical investigations 
used by physicians in the identification and management of liver disease. Many tests have 
been proposed for this purpose, but in practice, not every test is done. The King Edward 
VIII Hospital laboratories measure serum bilirubin, aspartate transaminase, alkaline phos-
phatase, gamma glutamyltransferase, and serum albumin. Prothrombin time and partial 
thromboplastin time are usually measured in the haematology laboratory; they are useful 
markers of the severity of hepatocellular disease, but are not regarded as conventional 
liver function tests (Mclntyre, 1983). 
The observation of van den Bergh and Muller in 1916 that some of the bilirubin in serum 
from jaundiced patients reacted directly with Erlich's diazo reagent, whereas some re-
quired alcohol for the development of colour (indirect bilirubin) was a major advance in the 
clinical chemistry of jaundice (Mclntyre, 1983). Malloy and Evelyn subsequently intro-
duced a quantitative version of the van den Bergh test that allowed measurement of the 
direct and indirect bilirubin in the blood (Malloy and Evelyn, 1937). The work done by 
Roberts on serum alkaline phosphatase activity in patients with a variety of conditions in 
1930 and in patients with jaundice in 1933 (Roberts, 1933), and King and Armstrong's 
description of their method of measurement of serum alkaline phosphatase a year later 
(King and Armstrong, 1934), were important contributions to the clinical chemistry of liver 
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disease. Another significant development was the observation made by De Ritis and co-
workers in 1955 that elevations of aspartate transaminase occur in viral hepatitis (De Ritis 
et al., 1955). Wroblewski and LaDue, in the same year, considered an elevated aspartate 
transaminase to be an index of liver cell injury when they found increased levels of this en-
zyme in acute hepatitis and other hepatic disorders (Wroblewski and LaDue, 1955). Con-





CAUSES OF HEPATOMEGALY AT KING EDWARD VIII HOSPITAL, 
DURBAN: A PROSPECTIVE STUDY OF 240 BLACK PATIENTS 
Introduction 
Patients admitted to the medical wards of King Edward VIII Hospital, Durban, frequently 
have enlargement of the liver which is incidental to the condition for which admission is 
required. This is usually not investigated unless it is the source of symptoms. 
Hersch stressed the need for liver biopsy in patients with unexplained hepatomegaly since 
hepatic tuberculosis often occurred without clinical or radiological evidence of pulmonary 
or extrahepatic involvement (Hersch, 1964 a,b). Furthermore, he emphasised that hepatic 
tuberculosis may present as pyrexia of unknown origin, or clinically simulate cirrhosis, liver 
abscess or carcinoma of the liver. 
Against this background a study was conducted to determine: 
i. the causes of hepatomegaly in patients admitted to the medical wards of King 
Edward VIII Hosptial; 
ii. the relative frequency of tuberculosis as a cause of hepatomegaly; and 
iii. the efficacy of liver biopsy in detecting pathology in patients with unexplained 
hepatomegaly. 
Patients and Methods 
During this prospective study, which commenced in February 1984, every patient admitted 
to the medical wards of King Edward VIII Hospital, Durban was examined for liver enlarge-
ment. In all, 240 black patients with an enlarged liver, irrespective of the admission diag-
nosis, were included in this study. 
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The cause of the hepatic enlargement was determined by clinical and, in most cases, sup-
plementary examination, including basic haematological and microbiological tests, 
ultrasound scans and liver biopsy using a "Tru-Cut" needle, as outlined below. 
Patients were not subjected to percutaneous liver biopsy if a cause for the enlarged liver 
could be established: 
i. on clinical grounds e.g. congestive cardiac failure; 
ii. by simple haematological tests e.g. leukaemia; 
iii. by ultrasonography e.g. amoebic liver abscess; 
iv. by microbiological tests e.g. typhoid fever; or 
v. by peritoneoscopy. 
The results of haematological and biochemical tests and other specialised investigations, 
and the response to therapy, where applicable, were recorded in all patients. 
Patients belonging to groups (i) - (v) above whose hepatomegaly did not respond as an-
ticipated to appropriate therapy, and all other patients who did not fall into these groups, 
underwent percutaneous "Tru-Cut" needle biopsy of the liver provided that: 
i. informed consent was obtained; 
ii. their coagulation profile was normal; and 
iii. no contraindication to biopsy was present. 
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Results 
A cause for the hepatomegaly was found in 153 patients (63.8%) without recourse to 
biopsy. The remaining 87 patients (36.3%) with unexplained hepatomegaly required liver 
biopsy. This was achieved in 76 patients (31.7%) without encountering any complications. 
Liver biopsy was not performed in the remaining 11 patients (4.6%) either because con-
sent was refused, a severe coagulation abnormality was present, or the clinician respon-
sible for management considered the patient too ill or biopsy unnecessary. 
A cause for hepatic enlargement was found in 69 (90.8%) patients in whom liver biopsy 
was carried out. The diagnoses made at liver biopsy are presented in Table 1a. 
When 3 specimens were submitted for histological examination, the diagnostic yield of 
liver biopsy was increased. A solitary granuloma which was present in only one of the 
three biopsy specimens provided a diagnosis in 2 cases. In another 2 patients in whom 
the initial biopsy specimen was unhelpful, a repeat biopsy, during which two specimens 
were taken, provided a diagnosis. In the 7 patients in whom liver biopsy failed to provide a 
diagnosis, it was found that only one specimen had been sent for histological examination. 
A cause for hepatomegaly was thus found in 92.5% of the 240 patients who were studied. 
The relative frequency of the various causes is presented in Table 2a. 
Tuberculosis of the liver, which accounted for 9.2% of patients whose hepatomegaly was 
initially unexplained and 2.9% of all patients studied, did not present any consistent clinical 
findings. There was no age or sex preponderance in these 7 patients. In 3 patients, the 
disease had not been associated with loss of weight. Fever was absent in 2 cases. The 
liver varied in size and in consistency and was tender in 2 patients. Splenomegaly was 
present in 3 patients. The chest radiograph was normal in 3 patients and in another 3 
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showed soft nodular shadows. The remaining patient had a right lower lobe bronchop-
neumonia. The ranges for the various liver function tests were as follows: albumin levels: 
18-33g/l (normal: 35-50g/l); globulin levels: 32-53g/l (normal: 25-30g/l); bilirubin levels: 
5-23umol/l (normal: up to 17umol/l) and alkaline phosphatase levels: 136-737U/I (normal: 
up to 95U/1). Two patients had an elevation of the alkaline phosphatase level which was 
less than twice normal. The haemoglobin concentration was normal in 1 patient. Sputum 
was unobtainable in 5 patients and negative for acid-fast bacilli in the remaining 2 patients. 
In all these patients, examination of liver biopsy specimens provided the only means of es-
tablishing a diagnosis of tuberculosis. Acid-fast bacilli were present in the liver in 4 cases. 
The liver and spleen decreased in size after treatment with anti-tuberculous drugs in all 
patients. 
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Siderosis and septal fibrosis 
Metastatic adenocarcinoma 
Miscellaneous: 
a. Viral hepatitis 
b. Intrahepatic cholestasis 
c. Liver abscess (pyogenic) 
d. Malignant histiocytoma 
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2a CAUSES OF HEPATOMEGALY IN 240 PATIENTS IN KING 
EDWARD VIII HOSPITAL MEDICAL WARDS 
PATIENTS 
Number Percent 
Congestive cardiac failure 










Other (causes with a frequency of <2.5%) 
a. Fatty change (2.1%) 
b. Siderosis and septal fibrosis (2.1%) 
c. Viral hepatitis 0-7%) 
d. Pyogenic abscess (1.3%) 





























Liver enlargement is a common finding in patients admitted to the medical wards of King 
Edward VIII Hospital, Durban. In this prospective study of 240 patients, a cause for the 
hepatomegaly was found in 153 (63.8%) of patients after clinical examination and the ap-
propriate use of haematological and microbiological tests and the ultrasound scan. Liver 
biopsy was performed in 76 of the remaining 87 patients without encountering complica-
tions. Liver biopsy provided the diagnosis in 90.8% of these patients. Thus a cause for 
liver enlargement was found in 222 (92.5%) of patients studied. 
The commonest cause was congestive cardiac failure (36.7%), followed by amoebic liver 
abscess (7.1%), hepatocellular carcinoma (5.8%), cirrhosis (5.4%), typhoid, lymphoma 
and leukaemia (4.6% each). 
It should be noted that tuberculosis accounted for 2.9% of all patients with hepatomegaly 
(and 9.2% of patients with an initially unexplained hepatomegaly), a frequency similar to 
that of alcoholic hepatitis and schistosomiasis. It is important, therefore, to consider tuber-
culosis as a possible cause when confronted with a patient with unexplained 
hepatomegaly. There are no characteristic features in patients with hepatic tuberculosis. 
A high index of suspicion is therefore required, especially in areas where tuberculosis is 
endemic. Liver biopsy is mandatory in these circumstances since it provides the only 
means of establishing the diagnosis. Moreover, tuberculosis of the liver may simulate cir-
rhosis, hepatocellular carcinoma and liver abscess clinically (Hersch, 1964 a,b), and the 
serum alkaline phosphatase may be normal in these patients. 
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The results suggest that when liver biopsy is carried out, three specimens should be ob-
tained for histological examination by using a single entry site and redirecting the biopsy 
needle; the diagnostic yield was improved without an associated increase in complica-
tions. 
The relative frequency of the various causes of hepatomegaly in our hospital population 
differed from that reported from other parts of Africa. In a study of 82 patients (which ex-
cluded patients with congestive cardiac failure) conducted at the University Teaching 
Hospital, Lusaka, toxic hepatitis (19.5%), viral hepatitis (14.6%), hepatocellular carcinoma 
(14.6%), cirrhosis (13.4%) and schistosomiasis (12.2%) were the major causes of 
hepatomegaly (Bahl et al., 1975). There were no patients with hepatic tuberculosis in this 
study. At the Mulago Hospital in Kampala, Uganda, cirrhosis, hepatocellular carcinoma, 
viral hepatitis and schistosomiasis played a major part in producing liver disease (Patel 
and Lwanga, 1971). In a study of 49 cases of obscure hepatomegaly conducted at Ain-
Shams University, Cairo, the pathological findings on examination of liver biopsy 
specimens were as follows: cirrhosis (15 patients), chronic non-specific liver infection (13 
patients); infiltration, necrosis, degeneration (8 patients); normal liver (3 patients); malig-
nancy (1 patient); undetermined (9 patients)(EI Mehairy, et al., 1969). Only 1 patient in this 




SAMPLING VARIABILITY AND ITS INFLUENCE ON THE DIAGNOSTIC 
YIELD OF PERCUTANEOUS NEEDLE BIOPSY OF THE LIVER 
Introduction 
Percutaneous needle biopsy of the liver is a useful device for detecting the presence and 
nature of hepatic pathology, but since only a very small portion of the liver is obtained, le-
sions that are not uniformly distributed throughout the organ may be missed. In order to 
improve the diagnostic accuracy of liver biopsy, more than one specimen may be taken 
when cirrhosis, chronic aggressive hepatitis, metastatic carcinoma, or granuloma is 
suspected (Abdi et al., 1979). Some investigators routinely perform two biopsies when 
liver metastases are suspected (Fernandez et al., 1963; Grossman et al., 1972). However, 
in a recent study, which excluded patients with suspected localised liver lesions, another 
group of investigators reported that a single liver biopsy was adequate for assessment of 
liver histology (Picciotto et al., 1984). 
A prospective study conducted to determine the causes of hepatomegaly in patients ad-
mitted to the medical wards of our hospital indicated that the diagnostic yield of liver 
biopsy could be improved when three consecutive biopsy specimens were obtained by 
redirecting the biopsy needle through a single entry site ; morbidity was not increased, 
provided that standard precautions were taken (Maharaj et al., 1986a). These preliminary 
findings required confirmation because an improved diagnostic yield not associated with 
an increase in complications would have important implications for patient management. 
A study was therefore designed to determine sampling variability and its influence upon 
the diagnostic yield of percutaneous needle biopsy when 3 consecutive specimens are 
taken during the procedure, and the nature and frequency of complications associated 
with this procedure. 
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Patients and Methods 
Biopsies were performed in the medical wards of King Edward VIII Hospital, Durban, by in-
terns trained in the technique (Hegarty and Williams, 1984). Consent for the procedure 
was obtained in all cases after a full explanation of its implications. 
Fifty-nine male and 16 female in-patients aged 12-70 years (mean 46.8 ± 17.0 years) in 
whom liver biopsy was indicated were included in the study. All had a platelet count 
greater than 100 x 109/l and prothrombin index greater than 75%. After infiltrating the skin 
and subcutaneous tissues with 2% lignocaine, 3 specimens were obtained using a 'Tru-
Cut" needle introduced through a single site and twice redirected by about 20° to 30° from 
the initial position (see figure). Thereafter, patients were monitored for complications 
(Hegarty and Williams, 1984); all were kept in hospital until a minimum of 24 hours had 
elapsed after the biopsy. Each specimen was placed in a separate bottle and coded so 
that their sampling order was unknown to the pathologists. After routine processing and 
staining, the 3 specimens were each examined by a different pathologist to eliminate any 
influence which findings on one biopsy specimen might have upon the interpretation of 
subsequent specimens from the same patient. The possibility of observer error between 
pathologists was reduced by submitting all biopsies to a single senior pathologist for 
review. All specimens were considered of adequate length for histological diagnosis 
(Sherlock, 1985). 
Reports on the biopsy findings in each patient were then collated and any normal 
specimen was allocated the letter "N". If histological abnormalities were present in a single 
specimen, or the same abnormality was detected in more than one of 3 specimens col-
lected from the same patient, the letter "A" was allocated to each such specimen. When 
pathological changes were present in more than one specimen but uniformity was lacking, 
"A" was used to indicate the specimen with least abnormalities and the letters "AA" and 
23 
"AAA" to denote specimens with pathology additional to that present in those coded "A" or 
"AA" respectively. Thus for each patient biopsied, the histological findings and symbol al-
located to the first, the second and the third specimen, and the presence (and nature) of 
complications were known. Patients with similar distributions of symbols in the sequential 
biopsies were grouped together. 
Schematic representation of the 
liver biopsy technique used in this study 
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Results 
The results obtained are presented in Table 1b. All specimens were normal in 11 patients 
(14.7%). In a further 27 patients (36%), the abnormalities present in all 3 specimens were 
similar. Thus, the findings were uniform in all 3 specimens in 50.7% of patients studied. In 
the remaining 49.3% (37 patients), sampling variability was found between the biopsy 
specimens. 
The first specimen yielded maximum information in 70.7% of the 75 patients studied. The 
second specimen provided additional information in 13.3%, and the third in 16%. Had the 
order been reversed so that the third specimen became the first and vice versa, maximum 
information would have been obtained from the first specimen in 74.7% of patients. The 
second specimen would then have provided additional information in 9.3%, and the third 
would have given further information in 16%. 
The influence of this sampling variability upon diagnoses that are frequently made by liver 
biopsy at our hospital (Maharaj et ai., 1986a) is presented in Table 2b, which shows the 
distribution of lesions in 3 consecutive biopsy specimens. Hepatocellular carcinoma was 
present in all 3 specimens in 54.5% of cases, cirrhosis in 50%, metastatic carcinoma in 
50%, and hepatic granulomas in 18.8% of cases. No sampling variability was found in the 
detection of alcoholic hepatitis (4 patients) and viral hepatitis (1 patient). The solitary case 
of angiosarcoma demonstrated this tumour in only the first specimen. Variability in the 
detection of fatty change and non-specific hepatitis was found in 1 patient. 
There were no complications in any of the 75 patients studied; none required narcotic 
analgesics, intravenous fluids, blood transfusion, or developed an acute abdomen. 
25 
Table 1 b. REPRESENTATION OF LIVER BIOPSY FINDINGS WHEN THREE 




















































































N = normal; A = abnormal; AA = abnormalities >A; AAA = abnormalities >AA 
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Table 2b. SAMPLING VARIABILITY IN THE DETECTION OF IMPORTANT 






Caseating tuberculoid granuloma 
Schistosomal granuloma 



























































































+ = present; - = not present 
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Discussion 
Sampling variability of considerable magnitude was present in the detection of cirrhosis, 
hepatocellular carcinoma, metastatic carcinoma and hepatic granulomas. In many of 
these cases the diagnosis would not have been made if only one biopsy specimen had 
been submitted for histological examination. 
Variability in the diagnosis of cirrhosis has been reported by other workers, (Abdi et al., 
1979; Baunsgaard et al., 1979; Soloway et al., 1971; Vido and Wildhirt, 1969; Waldstein 
and Szanto, 1950). With the use of a biopsy technique similar to that used in this study, 
Soloway and colleagues diagnosed cirrhosis in all 3 biopsy specimens in only 2 of 8 
patients with this disease and reported that when 3 sequential liver biopsies were obtained 
in the conventional manner over a 1-3 year period in patients with cirrhosis, histological 
evidence of the disease was not always found (Soloway et al., 1971). These authors con-
cluded that the failure to demonstrate cirrhosis on a single needle biopsy specimen in 
patients with chronic active liver disease offered no assurance that the lesion was not 
present (Soloway et al., 1971). Abdi and co-workers reported that cirrhosis was confirmed 
on the first biopsy specimen in 16 of their 20 autopsy-proven cases; diagnostic accuracy 
was increased to 100% after examining 3 specimens (Abdi et al., 1979). Vido and Wildhirt 
found that a single blind liver biopsy failed to demonstrate cirrhosis in 51% of 254 patients 
in whom the diagnosis had been made at peritoneoscopy (Vido and Wildhirt, 1969). In 
contrast, Braunstein, who performed multiple liver biopsies at autopsy, reported that a 
single needle biopsy was accurate in the recognition of cirrhosis. However, analysis of his 
findings reveals that the degree and distribution of fibrosis was consistent in only 6 of 30 
patients. Furthermore, in 5 patients who fulfilled the criteria for "far-advanced" cirrhosis, at 
least 1 specimen was found to be normal (Braunstein, 1956). A more recent report stated 
that a highly significant correlation existed between the findings at percutaneous liver 
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biopsy and those obtained after examination of both the percutaneous biopsy specimen 
and 2 specimens taken during peritoneoscopy (Picciotto et a!., 1984). However, the num-
ber of patients in whom cirrhosis was detected in all 3 biopsies is not mentioned. These 
authors appeared to prefer laparoscopy as a means of confirming this diagnosis; the 
reason for this was not stated. In another study a highly significant correlation was found 
between 2 percutaneous specimens in the detection of cirrhosis, although the diagnosis 
was made in both specimens in only 8 of 12 patients (Baunsgaard et al., 1979). 
Hepatocellular carcinoma was detected in all 3 specimens in 54.5% of patients with this 
diagnosis in our study. No other data on sampling variability in the diagnosis of this 
tumour are available for comparison. However, an autopsy-proven case of hepatocellular 
carcinoma involving the right lobe of the liver was missed by 3 sequential right costal liver 
biopsies in one study (Abdi et al., 1979). 
Metastatic carcinoma was uniformly represented in all three biopsy specimens in 50% of 
patients with this diagnosis. In a study conducted by Grossman and co-workers metas-
tatic carcinoma was diagnosed by the first biopsy in 41% of cases; diagnostic accuracy 
increased to 54% with 2 biopsies (Grossman et al., 1972). These workers now routinely 
perform two biopsies when trying to demonstrate liver metastases. Similar figures were 
obtained in other studies (Abdi et al., 1979; Conn and Yesner, 1963). 
Granulomas were found in all 3 specimens in only 18.8% of our patients with this lesion; 
this did not occur in schistosomiasis. A lack of uniformity in the presence of caseating 
tuberculoid granulomas was noted in 1 of 3 patients with this diagnosis. The detection of a 
solitary non-caseating tuberculoid granuloma (in only 1 of 3 specimens) influenced the 
management of 6 of 8 patients with this lesion. Because of the clinical suspicion of hepatic 
tuberculosis, appropriate therapy was commenced; 3 patients responded to treatment, 
and 3 were lost to follow-up. The seventh patient was subsequently found to have typhoid 
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fever and the significance of the granuloma in the remaining patient was uncertain. Liver 
biopsy is commonly carried out in patients with hepatomegaly or hepatosplenomegaly of 
uncertain aetiology and in patients with pyrexia of unknown origin in the hope of finding a 
treatable cause, such as tuberculosis. The magnitude of sampling variability found in the 
detection of hepatic granulomas in this study has important therapeutic implications. 
Sampling variablity (of lesser magnitude) has been reported in other studies (Abdi et al., 
1979; Klatskin and Yesner, 1950; Wagoner et al., 1951). 
There is a paucity of data on the frequency and nature of complications that occur when 2 
or more consecutive biopsy specimens are taken because studies on sampling variability 
have been conducted mainly in cadavers (Abdi et al., 1979; Braunstein, 1956; Grossman et 
al., 1972; Wagoner et al., 1951; Waldstein and Szanto, 1950), while most of those that have 
been performed in vivo make no mention of complications (Baunsgaard et al., 1979; Pic-
ciotto et al., 1984; Soloway et al., 1971). An increased incidence of minor complications 
has been found after 4 consecutive biopsies in a study in which 344 patients required be-
tween 2 and 11 biopsies (Perrault et al., 1978). We encountered no complications in our 
study. 
These findings demonstrate that important pathological abnormalities can be overlooked 
in patients with hepatic disease when liver biopsy is performed in the conventional man-
ner. Furthermore, the method used in this study, during which 3 specimens are obtained 
by using a single intercostal entry site and twice redirecting the biopsy needle about 20° to 
30° from the original direction, can be used by relatively inexperienced clinical staff 
(interns) without an increase in complications. The improved diagnostic yield achieved by 
using this method has important implications for patient management; its greatest impact 
will be in developing countries where cirrhosis, hepatocellular carcinoma, liver metastases, 
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and granulomatous liver disease, including tuberculosis and schistosomiasis, are impor-
tant and frequent causes of liver pathology (Bahl et al., 1975; El Mehairy et al., 1969; 




A PROSPECTIVE STUDY OF HEPATIC TUBERCULOSIS IN 
41 BLACK PATIENTS 
Introduction 
Many textbooks of clinical medicine fail to stress the importance of tuberculosis of the liver 
as a possible cause of hepatomegaly in areas where tuberculosis is endemic. In a 
prospective study conducted at King Edward Vlll Hospital, Durban, hepatic tuberculosis 
was diagnosed in 9% of patients with an initially unexplained hepatomegaly (Maharaj et al., 
1986a). Inconsistency in the clinical findings in this small group of seven patients with 
hepatic tuberculosis suggested that a high index of suspicion was required to avoid over-
looking this diagnosis and an expanded study was instituted to assess the accuracy of 
these preliminary findings. 
Patients and Methods 
This study was conducted at King Edward Vlll Hospital, which serves the black community 
of Durban and surrounding areas. During a 22-month period, patients in whom liver 
biopsy was carried out as part of the investigation of unexplained hepatomegaly, 
hepatosplenomegaly of uncertain cause or pyrexia of unknown origin were considered for 
inclusion in the study. Of the 48 patients entered initially, 41 with granuloma(s) in the liver 
were included in the final analysis because one of the following criteria for the diagnosis of 
hepatic tuberculosis was present: caseation or acid-fast bacilli in the liver; evidence of 
tuberculosis elsewhere; response to antituberculous treatment. 
The patients were aged between 21 and 75 years. In each case, the history, findings on 
physical examination, and results of haematological and biochemical tests and special in-




Hepatic tuberculosis was diagnosed in 41 black inpatients (24 male and 17 female). Their 
mean age was 44.5 ± 15.8 years. 
Forty-six per cent of patients had abdominal symptoms (usually pain in the right upper 
quadrant and distension), 61% had lost weight and 78% had respiratory symptoms 
(cough; dyspnoea; chest pain). The reasons for hospital admission in five patients were 
alcohol intoxication, confusion, seizures, recurrent pelvic inflammatory disease and urinary 
tract infection. Hepatic tuberculosis was an incidental finding. 
The physical findings are present in Table 1c. Pyrexia was noted in 63% of patients; in one 
patient the temperature settled within three days of starting co-trimoxazole for presumed 
bronchopneumonia. 
Jaundice, unrelated to antituberculous drugs, was present in 6(15%) patients; two 
developed hepatic encephalopathy which responded to appropriate treatment. Liver en-
largement ranged from 1 to 7 cm (mean 3.9 _+. 3.4cm) in the right midclavicular line and 
from 1 to 11cm (mean 3.8 _+_ 2.2cm) in the mid-thoracic line. In no case was 
splenomegaly greater than 4cm. 
The results of haematological and biochemical tests are presented in Table 2c. Anaemia 
(Hb<13g/dl in males and <12g/dl in females) (Report of a WHO Scientific Group, 1968) 
was detected in 73% of patients; the haemoglobin concentration was lower than 10g/dl in 
17% of patients. The white cell count was below 4x109/l in 4% of patients and elevated in 
17%. Thrombocytopenia (< 100x109/l) was noted in 7% of patients and thrombocytosis 
(> 450x109/l) in 12%. Pancytopenia was not observed. The prothrombin index was 
greater than 75% in 93% of patients; in the remaining three patients, the prothrombin index 
rose after the administration of vitamin K. 
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Hypoalbuminaemia (<35g/l) was present in 95% of patients and was severe (<20g/l) in 
38%. Hyperglobulinaemia (>35g/l) was noted in 78%, with levels greater than 50g/l in 
20% of patients. In 43% of patients the serum bilirubin concentration was raised; levels 
were greater than 40umol/l in 20%. 
Serum alkaline phosphatase levels were normal in 13% of patients; elevations equal to al-
most twice the normal value were noted in 20% of patients, while another 20% had eleva-
tions nearly three times the normal value. The mean serum sodium level wasl29.5 ± 
6.6mmol/l. Hyponatraemia was present in 66% of patients. The ascitic protein concentra-
tion was measured in eight patients; a transudate was present in three and an exudate in 
five patients (Bastani et al., 1985). 
Ultrasonography was normal in 17 of 18 (94%) patients who underwent this procedure. In 
the remaining patient, increased echogenicity of liver tissue was noted. Tc-99m sulphur 
colloid liver scans were obtained in 17 patients and were normal in eight (47%) patients. 
Decreased uptake of the radiocolloid by the liver with shunting to the spleen or bone mar-
row was noted in seven patients. An increased extrahepatic uptake was the only abnor-
mality in two patients. 
Chest radiographs were normal in 22% of patients. One patient had apical scarring. Two 
had ill-defined opacities in their upper lobes. Soft, nodular opacities were the most fre-
quent finding in the other patients. 
Percutaneous liver biopsy was carried out in 88% of patients and peritoneoscopic biopsy 
in the others. In addition to granuloma(s), caseation with acid-fast bacilli, caseation 
without acid-fast bacilli and acid-fast bacilli without caseation were detected in 37, 15 and 
22% of patients respectively. Thus, acid-fast bacilli were seen in 59% of patients. 
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Response to antituberculous treatment and evidence of tuberculosis elsewhere confirmed 
the diagnosis of hepatic tuberculosis in 27% of patients. Co-existing liver disease was 
present in 15 (37%) patients; two had alcoholic hepatitis, one had micronodular cirrhosis 
with alcoholic hepatitis, eight had siderosis plus septal fibrosis, and four had fatty change. 
Tuberculous peritonitis was diagnosed in one patient. 
It was not possible to monitor the response to antituberculous drugs (streptomycin, 
isoniazid, pyrazinamide and rifampicin) in all patients because they were often transferred 
to other hospitals and peripheral clinics. In 20% of patients, transfer was delayed until im-
provement had occurred. Their temperature responded after 7 to 16 days (mean 11 days). 
However, improvement in appetite occurred earlier, and increase in weight and reduction 
in the size of the liver and spleen were also noted. Two deaths were recorded. One 
patient died three days after starting treatment; isolated hepatic tuberculosis was con-
firmed at autopsy. The other died on the day treatment was started; autopsy was not per-
formed. 
36 











































Table 2c. LABORATORY DATA IN 41 PATIENTS WITH HEPATIC TUBERCULOSIS 




White cell count (X109/I) 




Alkaline phosphatase (umol/l) 










































































This study confirms that there are no consistent clinical findings in patients with tuber-
culosis of the liver. Abdominal symptoms, weight loss, pyrexia, hepatomegaly and 
splenomegaly were absent in 54, 39, 37, 5 and 68% of patients respectively. Analysis of 
the results of other studies, some of which include cases diagnosed at autopsy, confirms 
our finding that pyrexia and weight loss are not always present (Essop et al., 1984; Johri et 
al., 1970), jaundice is common (Alvarez and Carpio, 1983; Essop et al., 1984; Hersch, 
1964a) and liver failure does not imply a poor prognosis (Alvarez and Carpio, 1983; Essop 
et al., 1984). The liver is not invariably enlarged (Alvarez and Carpio, 1983; Essop et al., 
1984; Guckian and Perry, 1966; Ross et al., 1956) but, when it is, variation in size, consis-
tency and degree of tenderness occur (Alvarez and Carpio, 1983; Essop et al., 1984; 
Hersch, 1964a); 44% of our patients had a tender hepatomegaly. 
Biochemical abnormalities also lack consistency. Normal serum albumin and alkaline 
phosphatase levels were present in some of our patients, whereas severe hypoal-
buminaemia and marked elevations of serum alkaline phosphatase levels were noted in 
others. None of the patients studied by Johri and his colleagues had abnormal alkaline 
phosphatase levels (Johri et al., 1970), whereas Alvarez and Carpio (Alvarez and Carpio, 
1983) and Essop and co-workers (Essop et al., 1984) reported normal levels in 25 and 17% 
of their patients respectively. In the past, emphasis has been placed on the value of a dis-
proportionate elevation of the serum alkaline phosphatase level when hepatic granulomas, 
including tuberculosis, are suspected (Essop et al., 1984; Ross et al., 1956); it is now clear 
that the presence of normal alkaline phosphatase levels does not rule out hepatic tuber-
culosis (Essop et al., 1984; Frank and Raffensperger, 1965; Hersch, 1964a). Furthermore, 
in 48% of our patients, levels could not be distinguished from those associated with cir-
rhosis of the liver in our hospital (O'Keefe et al., 1982). Thus, our findings agree with those 
of Guckian and Perry, viz. that liver function tests are not of diagnostic value (Guckian and 
Perry, 1966), and support Spiro's view that normal liver function tests should not deter the 
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clinician from performing liver biopsy when disseminated tuberculosis is suspected (Spiro, 
1983). Our findings also support Mclntyre's contention that there is a tendency to read 
more into the results of liver function tests than the confirmation of liver disease, even 
though these tests alone have limited capability for differential diagnosis (Mclntyre, 1983). 
It is also important to note that transudative ascites does not exclude hepatic tuberculosis; 
transudates occurred in three of our patients, one of whom had concomitant tuberculous 
peritonitis. 
The fact that ultrasound and Tc-99m sulphur colloid liver scans were normal in 94 and 47% 
of patients respectively confirms that hepatic imaging techniques are of little value in this 
condition (Essop et al., 1984). Chest radiographs were normal in 22% of our patients. Al-
varez and Carpio reported that 35% of their patients had normal chest radiographs 
(Alvarez and Carpio, 1983). None of the patients studied by Johri and co-workers had ab-
normal radiographs (Johri et al., 1970). Thus, hepatic tuberculosis cannot be excluded by 
the absence of clinical or radiological evidence of pulmonary disease. Haematological 
abnormalities were also inconsistent. Anaemia was absent in 27% of patients. White cell 
and platelet counts were normal in the majority of patients, and both high and low counts 
were noted. Guckian and Perry reported that tuberculin skin testing was positive in only 
41% of patients; one of their eight patients with sarcoidosis also had a positive test 
(Guckian and Perry, 1966). 
In addition to hepatic tuberculosis, other forms of liver disease, including cirrhosis and al-
coholic hepatitis, were also detected on histological examination of the biopsy specimens 
from some patients. Not only can hepatic tuberculosis co-exist with other forms of liver 
disease, but it may also simulate cirrhosis, liver abscess and carcinoma of the liver 
(Alvarez and Carpio, 1983; Atoba and Junaid, 1980; Essop et al., 1984; Hersch, 1964a). 
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Since the clinical picture of hepatic tuberculosis is so variable a high index of suspicion is 
necessary, especially in communities where tuberculosis is endemic. Support for this is 
provided by Essop and co-workers who reported that this disease was suspected clinically 
in only 47% of their patients (Essop et al., 1984). A liver biopsy should be performed in 
patients with unexplained hepatomegaly or hepatosplenomegaly or pyrexia of unknown 
origin as it provides the only means of making the diagnosis. Since sampling variability in 
the detection of hepatic granulomas occurs, two consecutive biopsy specimens should, if 
possible, be obtained by redirecting the biopsy needle through a single intercostal entry 
site (Maharaj et al., 1986b). Work done in some institutions has shown that when more 
biopsies are performed, more granulomas are detected (Frank and Raffensperger, 1965; 
Guckian and Perry, 1966; Hersch, 1964a). 
Because caseation necrosis is not always found and acid-fast bacilli are difficult to detect, 
many workers accept the presence of a non-caseating granuloma as evidence of tuber-
culosis and accordingly begin antituberculous treatment (Alvarez and Carpio, 1983; Essop 
et al., 1984; Frank and Raffensperger, 1965; Hersch, 1964a; Johri et al., 1970; Spiro, 1983). 
Clinical response proves the diagnosis. It is noteworthy that acid-fast bacilli were seen in 
59% of our patients, a frequency much higher than that reported previously (Alvarez and 
Carpio, 1983; Essop et al., 1984; Frank and Raffensperger, 1965; Guckian and Perry, 1966; 
Johri et al., 1970; Hersch, 1964a). In 38% of these patients, caseation was absent. We 
believe that acid-fast bacilli should be sought because their presence provides unequivo-
cal evidence of the diagnosis, but it is important that adequate liver tissue be sent for his-
tological examination (Guckian and Perry, 1966). One author recommends laparotomy to 
confirm the diagnosis if needle biopsy is negative (Hersch, 1964a). 
Response to antituberculous treatment is monitored clinically. In keeping with previous 
reports, improvement in appetite occurred early. The temperature settled within two 
weeks (Johri et al., 1970; Terry and Gunnar, 1957), and regression of hepatomegaly and 
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splenomegaly, as well as weight gain were noted (Alvarez and Carpio, 1983; Johri et al., 
1970; Terry and Gunnar, 1957). The value of short-course chemotherapy in patients with 
hepatic tuberculosis has not yet been established. However, a recent report by Dutt and 
co-workers (Dutt et al., 1986) that short-course chemotherapy was successful in 95% of 
patients with other forms of extrapulmonary tuberculosis suggests that a similar outcome 
can be expected in patients with hepatic tuberculosis. 
This study illustrates that hepatic tuberculosis has no pathognomonic features. That a 
greater awareness of this condition is required is demonstrated by our study in which in-
creased use of liver biopsy in patients with unexplained hepatomegaly or 
hepatosplenomegaly and pyrexia of unknown origin resulted in the diagnosis being made 
in 41 black patients during a period of 22 months, whereas the condition was considered 




THE ROLE OF ULTRASONOGRAPHY AND SCINTIGRAPHY IN 
DETECTING FOCAL AND DIFFUSE LIVER DISEASE IN DEVELOPING 
COUNTRIES 
Introduction 
Radionuclide scintigraphy and ultrasonography are used in many countries to evaluate 
patients in whom liver disease is supected. However, these imaging modalities are not 
readily available in developing countries. In response to the growing desire of developing 
countries to acquire equipment for imaging, a group of experts, who were chosen by the 
World Health Organisation, recommended that equipment for ultrasonography be pur-
chased (Palmer, 1985). They argued that even for those radionuclide scanning proce-
dures that had not become obsolete as a result of newer methods of imaging such as 
ultrasonography, certain difficulties existed, including the supply of the required 
radioisotopes in developing countries. Furthermore, this imaging modality did not 
demonstrate the nature of the disease or give sufficiently accurate anatomical information 
when abnormalities were detected. 
In the light of the fact that greater use of ultrasonography could result from this recommen-
dation, and that most of the publications on hepatic imaging have emanated from 
developed countries where the pattern of liver disease is likely to differ from that encoun-
tered in developing countries (Atoba and Junaid, 1980; Bahl et al., 1975; El Mehairy et al., 
1969; Maharaj et al., 1986a; Patel and Lwanga, 1971), a study was conducted to determine 
the role of ultrasonography and scintigraphy in the detection of focal and diffuse liver dis-
ease in developing countries. 
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Patients and Methods 
Patient Population 
This retrospective study was conducted at King Edward VIII Hospital, Durban. Ultrasound 
and scintigraphic liver scans can be requested by any member of the hospital staff, and 
are carried out by a radiologist or radiologist-in-training. 
Patient Selection 
A list of all patients in whom liver biopsy had been carried out during 1984-1987 (inclusive) 
was obtained from the Department of Anatomical Pathology. Their hospital records were 
reviewed to determine if an ultrasound and/or scintigraphic liver scan had been per-
formed. 
When either imaging procedure had been carried out, patients were considered for entry 
into the study and the following information was recorded: the temporal relationship of the 
scan(s) to the liver biopsy, the clinical history, findings on physical examination, the results 
of special investigations, including the liver biopsy and scan findings, final diagnosis and 
response to appropriate therapy (where applicable). 
Liver biopsy had been carried out in patients suspected of having either focal or diffuse 
liver disease because they had either unexplained liver or splenic enlargement or both, 
deranged liver function tests, jaundice, fever of unknown origin, unexplained weight loss, 
lymphoma, or abnormalities detected during hepatic imaging studies, peritoneoscopy or 
laparotomy. Liver tissue had been obtained during either percutaneous liver biopsy, 
peritoneoscopy or laparotomy. 
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Because liver biopsy is normally not used in the management of patients with amoebic 
liver abscess, a common disease encountered at our hospital, a list of all patients in whom 
this diagnosis had been made during the study period was obtained from the hospital 
computer and their hospital records reviewed. Patients were considered for inclusion in 
the study when either imaging procedure had been performed and when the criteria for the 
diagnosis of amoebic liver abscess were fulfilled. 
Histology 
Liver tissue submitted for histological examination was processed and stained in a routine 
manner. Special staining procedures were also used when indicated. All specimens were 
examined by a senior pathologist. 
Assignment of Final Diagnosis 
Amoebic liver abscess was diagnosed when amoebic serology was positive, aspiration 
yielded "anchovy-sauce" pus or treatment with metronidazole produced a beneficial 
response. 
In all other cases, the diagnosis was made by histological examination of liver tissue ob-
tained during percutaneous liver biopsy, peritoneoscopy or laparotomy. Because sam-
pling variability influences the diagnostic yield of liver biopsy, important pathology can be 
overlooked in patients with hepatic disease when liver biopsy is carried out in the conven-
tional manner. Accordingly, careful consideration was given to the clinical findings, results 
of other investigations, and findings at laparotomy or autopsy in all cases. 
In the event of dual pathology, the disease which was more likely to influence the prog-
nosis of the patient was selected as the primary pathology. 
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A separate category of "Carcinoma - Primary or Secondary1' was created because there 
were cases in which the pathologist was unable to decide whether the carcinoma was a 
primary hepatocellular carcinoma or a metastatic carcinoma. The clinical records and 
other investigations were unhelpful in distinguishing between the two diseases. An 
ultrasound diagnosis of either hepatocellular carcinoma or metastatic carcinoma was ac-
cepted as correct in cases that fell into this category. 
No attempt was made to determine the source of metastases in patients with metastatic 
carcinoma of the liver. 
Inclusion and Exclusion Criteria 
Patients were entered into the study provided that none of the following exclusion criteria 
was present: 
i. the interval between the imaging procedure and liver biopsy was greater than two 
weeks; 
ii. liver tissue was considered inadequate for histological diagnosis; 
iii. liver biopsy was deemed to have missed a lesion or if there was doubt about the 
final diagnosis; 
iv. siderosis, septal fibrosis, or fatty change was considered to be of mild or 
moderate degree by the pathologist; 
v. extrahepatic biliary obstruction was present; 
vi. a liver scan was considered technically suboptimal by either radiologist. 
Imaging Technique 
Radionuclide liver scintigraphy was performed 20 minutes after the administration of 2 to 4 
mCi of technetium-99m tin colloid. Scintigraphy was done with a large field of view 
gamma camera (Elscint Apex 415, Elscint, Haifa, Israel). A high resolution parallel hole 
collimator (APC - 3) was used. Anterior, posterior and right lateral views were obtained. 
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The ultrasound scans were obtained using commercially available real-time sector scan-
ners with a 3-3.5 MHz transducer (ATL-Mark 100 and ATL-Ultramark 8, Advanced Tech-
nological Laboratories, Bellevue, USA). Routine transverse and longitudinal scans were 
carried out. When indicated, oblique and other planes were used. The diagnostic echo 
patterns were obtained at standard instrument settings, although higher gain settings were 
required for optimal results in some patients. 
All scans were recorded on a "Cronex" daylight film which is clear-based. 
Interpretation of Scans 
Each scan was identified only by a code number and assessed without knowledge of the 
patient's clinical details, results of any investigations (including liver biopsy) or the final 
diagnosis. All scans were examined by two senior radiologists who worked independently 
of each other. Their observations and interpretations were recorded in a pre-arranged 
manner which is outlined below; in each case they were required to record their diagnostic 
impression (normal, diffuse parenchymal liver disease, focal liver disease). 
The report of the person who initially performed the imaging study (radiologist-in-training 
or specialist radiologist) was also interpreted by the author in a similar fashion; when the 
report suggested that diffuse or focal liver disease was present, this was taken to represent 
a categoric judgement on the presence of the abnormality for the purpose of this study. 
Each scintigraphic scan was read for homogeneity of uptake, presence or absence of ex-
trahepatic uptake or space-occupying lesions ("cold areas"). Diffuse liver disease was 
taken to be present when any of the following was detected: decreased and/or irregular 
liver uptake, increased splenic uptake, increased bone marrow uptake. Splenic enlarge-
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ment was not regarded as a sign of diffuse liver disease because there are many other 
causes of splenomegaly in our hospital. A focal area of decreased uptake was indicative 
of a space-occupying lesion. 
For each ultrasound scan, a comment was made on the echogenicity of the liver 
parenchyma and on the diagnostic impression (normal, diffuse parenchymal liver disease, 
space-occupying lesion). Echogenicity of liver parenchyma was considered increased if 
the density of echoes in the liver was greater than that in the parenchyma of the right kid-
ney. 
A focal area of increased, decreased or mixed echogenicity was considered consistent 
with a space-occupying lesion. A final diagnosis was made whenever the features of the 
space-occupying lesion were characteristic of a particular disease. In all other cases a dif-
ferential diagnosis was offered. Since hepatocellular carcinoma may affect the liver in a 
diffuse manner (Kamin et al., 1979), a diffusely coarse and disorganised echo pattern was 
accepted as indicating infiltration of the liver by neoplasia whenever the radiologist inter-
preted the ultrasound as such. 
A diffuse increase in echogenicity was interpreted as diffuse parenchymal liver disease. 
Splenomegaly and ascites were not used as signs of liver disease in this study because 
causes of these abnormalities, other than portal hypertension, are frequently encountered 
in this hospital. Because there is no consensus on whether it is consistently possible to 
distinguish between the various causes of diffuse parenchymal liver disease at ultrasonog-
raphy, and because there are many causes of diffuse liver disease at our hospital, it was 




After both radiologists had completed their assessment of the scans their reports were col-
lated. Differences were resolved at a consensus meeting. The reports in which there was 
agreement between the two radiologists and their joint report from the consensus meeting 
(in those cases lacking uniformity) were used in the analysis of the accuracy of the liver 
scans, and of the interobserver differences between the radiologist who initially carried out 
the imaging procedure and the two senior radiologists. The results of each scan was com-
pared with the final diagnosis and classified as true positive, false negative, true negative 
and false positive. 
Analysis 
Each technique was assessed sequentially for its accuracy in differentiating normal from 
abnormal liver, space-occupying lesions (focal liver disease) from diffuse liver disease and 
normal livers, and diffuse parenchymal liver disease from space-occupying lesions and 
normal livers, and its accuracy in detecting space-occupying lesions in patients with 
amoebic liver abscess, hepatocellular carcinoma, metastatic carcinoma and carcinoma-
primary or secondary, and diffuse liver disease in patients with cirrhosis, severe siderosis 
and septal fibrosis, severe siderosis, alcoholic hepatitis, hepatitis due to other causes, fatty 
change, tuberculosis, schistosomiasis and granulomatous liver disease including tuber-
culosis and schistosomiasis. 
In addition, the accuracy of ultrasonography in both detecting a space-occupying lesion in 
and making a correct diagnosis of amoebic liver abscess, hepatocellular carcinoma, 
metastatic carcinoma and carcinoma-primary or secondary, and the accuracy of each im-
aging procedure in detecting diffuse parenchymal liver disease in patients in whom cir-
rhosis co-existed with hepatocellular carcinoma was assessed. 
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This was done by calculating the sensitivity, specificity, accuracy, accuracy of a positive 
test and accuracy of a negative test for each technique from the test results. Sensitivity is 
the number of true positive studies divided by the sum of the true positive and false nega-
tive results and indicates the proportion of patients with the disease whose imaging study 
was correctly interpreted as positive. Specificity is the number of true negative studies 
divided by the sum of the true negative and false positive studies and refers to the propor-
tion of patients with no disease whose imaging study was correctly interpreted as nega-
tive. Accuracy, which denotes the proportion of patients whose imaging studies were cor-
rectly interpreted as positive or negative, is calculated by dividing the sum of true positive 
and true negative results by the sum of true positive, false negative, true negative and false 
positive results. The accuracy of a positive test, which describes the probability that the 
patient actually has the disease given that the patient has a positive test, is the number of 
true positive studies divided by the sum of true positive and false positive studies. The ac-
curacy of a negative test describes the probability that the patient is actually normal given 
that the patient has a negative test and is calculated by dividing the number of .true nega-
tive studies by the sum of true negative and false negative studies. Since the accuracy of 
a positive test depends on the prevalence of the disease, this was calculated by dividing 
the number of patients with the disease (true positive plus false negative) by the total num-
ber of patients being imaged (the sum of true positive, false negative, true negative and 
false positive studies) (Ashare, 1980; McClees and Gedgaudas-McClees, 1984; McNeil and 
Adelstein, 1976; Powell-Jackson et al., 1987). 
The interobserver variability between the two senior radiologists for each technique, as 
well as the interobserver variation between the person who initially performed the proce-
dure and the two senior radiologists was determined. This step was taken because it is 
the initial report that influences the further management of patients. 
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No attempt was made to determine the cause of false positive scintigraphic or ultrasound 
examinations as these have been extensively studied by other workers and adequate ex-
planations have been given, nor was an attempt made to determine the size of space-
occupying lesions in this study. 
Results 
There were 599 patients who fulfilled the inclusion criteria; nine patients had been ex-
cluded because their scans were considered technically suboptimal and uninterpretable. 
Table 1d shows the final diagnosis of the patients studied and the number of ultrasound 
and scintigraphic scans examined; ultrasonography was more frequently utilised than 
scintigraphy in all 3 patient categories. Both procedures were carried out in 131 patients, 
71 with focal liver disease, 44 with diffuse liver disease and 16 normal patients. 
The comparative accuracy of ultrasonography and scintigraphy in distinguishing between 
normal and liver disease is shown in Table 2d. Ultrasound scanning had a lower sen-
sitivity, higher specificity, lower accuracy, similar accuracy of a positive test and a lower 
accuracy of a negative test than scintigraphic scanning. The sensitivity, accuracy, and the 
accuracy of a negative test was low for both imaging techniques. 
In the detection of focal liver disease (space-occupying lesions), ultrasonography was 
noted to have a lower sensitivity, a higher specificity, a similar overall accuracy, a higher 
accuracy of a positive test and a lower accuracy of a negative test than scintigraphy (Table 
3d). However, with the exception of the sensitivity of ultrasonography which remained 
lower than that of scintigraphy, the trend in the detection of diffuse liver disease was dif-
ferent (Table 3d). Ultrasound scanning had a similar specificity, a lower accuracy, a lower 
accuracy of a positive test, and a similar accuracy of a negative test. The sensitivity of 
both procedures in diffuse disease was low. Both imaging modalities proved superior in 
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detecting space-occupying lesions; the sensitivity, accuracy, and accuracy of a negative 
test of both investigations and the accuracy of a positive ultrasound scan were higher in 
focal disease, while the specificity of both procedures and the accuracy of a positive scin-
tigraphic scan was similar in both focal and diffuse liver disease (Table 3d). 
The accuracy of ultrasonography and scintigraphy in detecting space-occupying lesions in 
patients with amoebic liver abscess, hepatocellular carcinoma, metastatic carcinoma and 
carcinoma-primary or secondary is shown in Tables 4d and 5d respectively. The sen-
sitivity of ultrasonography and scintigraphy ranged from 62 to 100% and 82 to 100% 
respectively, specificity of ultrasonography for all diseases was 98% and of scintigraphy 
ranged from 93-94%, accuracy of ultrasonography and scintigraphy ranged from 96-98% 
and 92-94% respectively, the accuracy of a positive test from 62-90% and 39 to 76% 
respectively, and accuracy of a negative test from 97 to 100% for both procedures. 
The accuracy of ultrasonography and scintigraphy in detecting diffuse liver disease in 
patients with cirrhosis, severe siderosis and fibrosis, severe siderosis, alcoholic hepatitis, 
hepatitis due to other causes, fatty change, tuberculosis and schistosomiasis is shown in 
Tables 6d and 7d. The sensitivity of ultrasonography and scintigraphy ranged from 0 to 
60% and 20 to 80% respectively, the specificity of ultrasonography for all diseases was 
97% and of scintigraphy ranged from 95 to 96%, accuracy of ultrasonography and scintig-
raphy ranged from 88 to 96% and 90 to 95% respectively, the accuracy of a positive test 
from 0 to 52% and 8 to 72%, and the accuracy of a negative test from 90 to 99% and 93 to 
99% respectively. 
53 
In the detection of diffuse liver disease in all patients with granulomatous liver disease 
(including tuberculosis and schistosomiasis), the sensitivity and accuracy of a positive test 
was lower for ultrasonography than scintigraphy (Table 8d). However, the sensitivity and 
accuracy of a positive test was low for both procedures. The specificity, accuracy and ac-
curacy of a negative test of the two imaging techniques were similar. 
When evaluating the ability of ultrasonography to both detect a space-occupying lesion in, 
and make a correct diagnosis of, amoebic liver abscess, hepatocellular carcinoma, metas-
tatic carcinoma and carcinoma (primary or secondary), scans of patients with the ap-
propriate disease were classified as false negative if a space-occupying lesion was not 
detected, or if a space-occupying lesion was detected and a final diagnosis was either not 
made (i.e. a differential diagnosis was given), or was incorrect. The results are presented 
in Table 9d. The sensitivity ranged from 29 to 81%, specificity from 94 to 99%, accuracy 
from 86 to 96%, accuracy of a positive test from 26 to 93% and the accuracy of a negative 
test from 87 to 97%. 
When the accuracy of the two imaging modalities in distinguishing between normal and 
liver disease in those patients (n = 131) who had both investigations (Table 10d) is com-
pared to that observed in all patients studied (Table 2d), the trend is similar, although the 
figures differ. 
The accuracy of ultrasound and radionuclide scintigraphic scanning in detecting focal and 
diffuse disease in the patients who had both investigations is shown in Table 11d. In both 
types of liver disease, ultrasonography was noted to have a lower sensitivity, a similar 
specificity, a lower accuracy, a similar accuracy of a positive test, and a lower accuracy of 
a negative test than scintigraphy. In this group of patients, the specificity, accuracy and 
accuracy of a positive test in focal disease of scintigraphy, accuracy of a positive test of 
both procedures in diffuse disease, and accuracy of a negative scintigraphic test in diffuse 
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disease were higher than that noted in the whole study (Table 3d) and would account for 
the discrepancies noted in the performance of the two procedures in all patients studied 
compared to the smaller subset who had both investigations. It is noteworthy that in both 
types of liver disease, the sensitivity of ultrasonography was lower than that of scintig-
raphy, in keeping with the observations in all patients studied. Also in this group of 
patients, the sensitivity of both procedures in diffuse disease was low (Table 11d). 
Agreement between the findings at ultrasonography and scintigraphy was present in 58 of 
71 patients with focal liver disease, 22 of 44 patients with diffuse disease and 15 of 16 
patients with a normal liver who had both procedures (Table 12d). The results were cor-
rect (true positive) in all, except one, of the patients with focal disease in whom the find-
ings of both techniques concurred. In contrast, in the majority of patients with diffuse liver 
disease, the results were false negative. 
The scintigraphic findings were correct in 12 of 13 patients with focal disease and 16 of 22 
patients with diffuse liver disease in whom agreement between the results of the two imag-
ing modalities was lacking (Table I2d). 
The sensitivity of ultrasound and scintigraphic scanning in detecting cirrhosis (diffuse liver 
disease) in patients who had both cirrhosis and hepatocellular carcinoma was 41 and 67% 
respectively (Table 13d); the other calculations were not done, because it was not pos-
sible to determine whether the remaining patients with hepatocellular carcinoma had cir-
rhosis since the specimens that were submitted for histological examination consisted en-
tirely of tumour tissue. 
Of the 41 false negative ultrasound scans in cirrhosis, 23(56%) occurred in patients with 
micronodular cirrhosis, 2 (4.9%) in macronodular cirrhosis and 16 (39%) in the mixed type 
of cirrhosis. Five (27.7%) false negative scintigraphic scans belonged to the first group, 3 
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(16.7%) to the second group and 10 (55.6%) to the third group. There were 12 scin-
tigraphic scans of patients with cirrhosis which were false positive for space-occupying le-
sions. They were distributed among the three groups as follows : 3(25%), 5(41.6%) and 
4(33.3%) respectively. An ultrasound scan of a patient with micronodular cirrhosis and 2 
ultrasound scans of patients with the mixed type of cirrhosis were incorrectly interpreted 
as having space-occupying lesions. 
Interobserver differences in the detection of focal liver disease, diffuse disease and normal 
liver were frequent with both imaging modalities (Table 14d). The two senior radiologists 
differed on 25.5% of ultrasound scans and 11% of scintigraphic scans of patients with dif-
fuse liver disease; the magnitude of the differences between the initial observer who 
carried out the procedure and the two senior radiologists was greater - 30.3% and 20.5% 
respectively. With the exception of the interobserver differences between the two senior 
radiologists for scintigraphic scans in normal individuals, which occurred in 14.5% of 
scans, the frequency of interobserver differences in focal disease and normal liver were 
much lower than in diffuse liver disease. Overall, interobserver differences were more fre-
quent for ultrasound scans. 
It was also noted that the two senior radiologists differed in their interpretation of 72 of the 
217 (33.2%) ultrasound scans of patients with focal liver disease in whom they had both 
correctly detected the presence of space-occupying lesions. In some instances, one of-
fered a differential diagnosis while the other made a final diagnosis. In other instances, 
one made a final diagnosis which was correct, while the other did not. 
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Table 1d. FINAL DIAGNOSIS IN THE 599 PATIENTS STUDIED. 
FOCAL DISEASE 










Severe siderosis + fibrosis 
Severe siderosis 
Alcoholic hepatitis 









































































TOTAL 599 425 304 
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Table 2d. ACCURACY OF ULTRASONOGRAPHY AND SCINTIGRAPHY 
IN DISTINGUISHING BETWEEN NORMAL LIVER AND 
LIVER DISEASE IN PATIENTS WITHOUT AND 












































Table 3d. ACCURACY OF ULTRASONOGRAPHY AND SCINTIGRAPHY 
IN DETECTING FOCAL OR DIFFUSE LIVER DISEASE. 
FOCAL DISEASE DIFFUSE DISEASE 
Ultrasound Scintigraphic Ultrasound Scintigraphic 
scans scans scans scans 
Scans of patient with 
the disease 































































Table 4d. ACCURACY OF ULTRASONOGRAPHY IN DETECTING SPACE-OCCUPYING 
LESIONS IN PATIENTS WITH CERTAIN FINAL DIAGNOSES FALLING 
INTO THE CATEGORY OF FOCAL LIVER DISEASE. 
Scans of patients with 
the disease 









































































Table 5d. ACCURACY OF SCINTIGRAPHY IN DETECTING SPACE-OCCUPYING LESIONS 
IN PATIENTS WITH CERTAIN FINAL DIAGNOSES FALLING INTO THE 
CATEGORY OF FOCAL LIVER DISEASE. 
Scans of patients with 
the disease 









































































Table 6d. ACCURACY OF ULTRASONOGRAPHY IN DETECTING DIFFUSE LIVER DISEASE 
IN PATIENTS WITH CERTAIN FINAL DIAGNOSES FALLING INTO THE 
CATEGORY OF DIFFUSE LIVER DISEASE. 
Scans of patients 
with the disease 
Scans of patients 













Cirr- Severe Severe Alcoh- Hepat- Fatty Tuber- Schisto-
hosis sider- sider- olic itis- change culosis somiasis 
osis osis hepat- other 





































































0.08 0.45 0.08 0.33 0.20 0.02 
0.90 0.98 0.99 0.98 0.98 0.99 0.97 0.97 
0.13 0.02 0.02 0.04 0.02 0.03 0.04 0.04 
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Table 7d. ACCURACY OF SCINTIGRAPHY IN DETECTING DIFFUSE LIVER DISEASE 
IN PATIENTS WITH CERTAIN FINAL DIAGNOSES FALLING INTO THE 
CATEGORY OF DIFFUSE LIVER DISEASE. 
Cirr- Severe Severe Alcoh- Hepat- Fatty Tuber- Schisto-
hosis sider- sider- olic itis- change culosis somiasis 
osis osis hepat- other 
+ fib- itis 
rosis 
Scans of patients 
with the disease 
Scans of patients 




































































































Prevalence 0.16 0.02 0.04 0.03 0.02 0.02 0.05 0.05 
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Table 8d. ACCURACY OF HEPATIC IMAGING IN DETECTING DIFFUSE LIVER 
DISEASE IN ALL PATIENTS WITH GRANULOMATOUS LIVER 
DISEASE (INCLUDING TUBERCULOSIS AND 
SCHISTOSOMIASIS). 
Granulomatous liver disease 










































Table 9d. DIAGNOSTIC ACCURACY OF ULTRASONOGRAPHY IN BOTH DETECTING 
A SPACE-OCCUPYING LESION AND MAKING A CORRECT FINAL 
DIAGNOSIS. 
Scans of patients 
with the disease 
Scans of patients 






































































Table 10d. ACCURACY OF ULTRASONOGRAPHY AND SCINTIGRAPHY 
IN DISTINGUISHING BETWEEN NORMAL LIVER AND 












Positive Test 0.97 0.97 
Accuracy of 
Negative Test 0.25 0.38 
























Table 11d. ACCURACY OF ULTRASONOGRAPHY AND SCINTIGRAPHY IN DETECTING 
DIFFUSE OR FOCAL LIVER DISEASE IN PATIENTS WHO HAD BOTH 
INVESTIGATIONS. 
FOCAL DISEASE DIFFUSE DISEASE 
Ultrasound Scintigraphic Ultrasound Scintigraphic 
scans scans scans scans 
Scans of patients with 
the disease 

























































Prevalence 0.54 0.54 0.34 0.34 
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Table 12d. DEGREE OF AGREEMENT BETWEEN FINDINGS AT ULTRASONOGRAPHY 






























Total 71 43 16 
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Table 13d. ACCURACY OF ULTRASONOGRAPHY AND SCINTIGRAPHY IN 
DETECTING CIRRHOSIS (DIFFUSE LIVER DISEASE) IN 






(n = 28) 22 18 
True Positive 9 12 
False Negative 13 6 
Sensitivity 0.41 0.67 
69 
Table 14d. INTEROBSERVER DIFFERENCES BETWEEN THE TWO SENIOR 
RADIOLOGISTS (OBSERVER 1 AND 2) AND BETWEEN THE 
INITIAL OBSERVER (OBSERVER 3) AND THE TWO 
SENIOR RADIOLOGISTS IN DETECTING NORMAL, 
DIFFUSE AND FOCAL LIVER DISEASE ON 






Observer 1 & 2 
Ultrasound Scintigraphic Ultrasound Scintigraphic 
scans scans scans scans 
DIFFUSE DISEASE 
Total no. of scans 
No. of differences 
% of differences 
FOCAL DISEASE 
Total no. of scans 
No. of differences 
% of differences 
NORMAL 
Total no. of scans 
No. of differences 
% of differences 
TOTAL 
Total no. of scans 
No. of differences 



















































A hepatic imaging procedure is usually requested to determine if liver disease is present. 
The two most important parameters when assessing the accuracy of an examination per-
formed in screening for disease are the sensitivity and accuracy of a negative test 
(McClees and Gedgaudas- McClees, 1984). Patients with positive screening examinations 
are more likely to be subjected to further studies to delineate the nature of a detected le-
sion better. It is important that a screening examination should not miss disease which is 
present, even at the risk of obtaining a few false positive results. Therefore, high sensitivity 
is of paramount importance in this situation. It is also important for the physician to have 
confidence in a negative screening examination if further investigations are to be avoided. 
The accuracy of a negative test is as important as sensitivity (McClees and Gedgaudas-
McClees, 1984). In the present study, which includes patients with a wide spectrum of dis-
eases, the sensitivity of both ultrasonography and scintigraphy in detecting liver disease 
was low (63% and 72% respectively), and the accuracy of a negative test was even lower 
(31% and 39% respectively), indicating that the role of these procedures in screening for 
liver disease in this environment is limited. In contrast, in a review of all published reports 
on studies in which ultrasonography and scintigraphy had been used to screen for the 
presence of liver disease, it was found that the sensitivity (75% and 86% respectively) and 
accuracy of a negative test (76% and 83% respectively) of both techniques were higher 
(McClees and Gedgaudes-McClees, 1984). These workers also reported that the sen-
sitivity of scintigraphy and accuracy of a negative scintigraphic test in diffuse liver disease 
were 87% and 91% respectively; figures for ultrasonography were not given (McClees and 
Gedguadas-McClees, 1984). These results are dissimilar to ours. The sensitivity of scintig-
raphy was 54%. The sensitivity in the diseases which were included in this category 
ranged from 20-80%. This study confirms previous reports that the abnormalities detected 
during hepatic scintigraphy occur in many conditions which disturb normal architecture 
and function, and are not characteristic of any of these (Ackery and Smith, 1985), that dif-
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fuse parenchymal liver disease is frequently inseparable from normal and will continue to 
be difficult to detect with this technique (Nishiyama et al., 1975), and that scintigraphy is of 
little diagnostic value in hepatic tuberculosis (Essop et al., 1984; Maharaj et al., 1987a). 
Thus, despite the fact that its sensitivity was twice that of ultrasonography, this imaging 
modality is of little value in screening for diffuse liver disease. It is noteworthy that in 
patients in whom the findings of the two imaging techniques disagreed, scintigraphy was 
more often correct. 
The performance of ultrasonography in the detection of diffuse liver disease in the present 
study was poor; the sensitivity was 27% and the accuracy of a negative test was 74%; al-
coholic hepatitis and fatty change were the only diseases in which the sensitivity exceeded 
50%. In the other diffuse diseases, it ranged from 0% to 24%. The sensitivity of 
ultrasonography in detecting diffuse disease in patients with cirrhosis plus hepatocellular 
carcinoma was also low (41%). This study indicated that severe siderosis plus fibrosis 
does not produce any ultrasonographic abnormalities and will always be missed by this 
imaging modality. The sensitivity in hepatic tuberculosis was extremely low and confirms 
an earlier report that ultrasonography is of no diagnostic value when this treatable disease 
is suspected (Maharaj et al., 1987a). In another investigation, it was reported that in-
creased echogenicity was noted in 7 patients; the number of patients who underwent this 
procedure is not stated (Essop et al., 1984). It is also evident that only a minority of 
patients with hepatic schistosomiasis, a granulomatous liver disease which has recently 
been noted to occur with a frequency similar to that of hepatic tuberculosis at this institu-
tion (Maharaj et al., 1986a), will be detected by ultrasonography. It has been stated that, 
due to their small dimensions, the granulomas are usually not detected by ultrasound 
studies (Cerri et al., 1984). These workers have described the ultrasonographic features of 
hepatosplenic schistosomiasis and indicated that this condition can easily be distin-
guished from cirrhosis (Cerri et ai., 1984). It is possible that if the criteria they described 
were used in the present study, more patients could have been detected. The findings in 
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the present study also support the conclusion that ultrasonography does not provide infor-
mation useful in the diagnosis of viral hepatitis (Giorgio et al., 1986). Abnormal ultrasound 
examinations were present in only 24% of patients with cirrhosis. Of the false negative 
scans, 56% occurred in patients with micronodular cirrhosis. It has been previously recog-
nised that ultrasonography fails to detect macronodular cirrhosis more often than 
micronodular cirrhosis (Dewbury and Clark, 1979). It could be argued that the sensitivity 
of ultrasonography would have been improved had ancillary signs of cirrhosis been in-
cluded in the present study. The rationale for not using the ancillary signs was that their 
presence did not imply that cirrhosis was the diagnosis; in this environment there are a 
number of causes of portal hypertension, including schistosomiasis and portal vein throm-
bosis, and of ascites, including peritoneal tuberculosis. The sensitivity of ultrasonography 
in alcoholic hepatitis and fatty change was 56% and 60% respectively. However, this 
figure is not high enough to make this a satisfactory screening procedure. The accuracy 
of a positive ultrasonographic test in all forms of diffuse liver disease was low. In addition, 
interobserver differences between the two senior radiologists were present in 25% of 
ultrasound scans of patients with diffuse liver disease. 
The present study indicates that diffuse liver disease can frequently not be distinguished 
from normality by ultrasonography, and that liver biopsy will continue to play an important 
role in detecting the presence and nature of diffuse liver disease. Our deductions are sup-
ported by the work of others. In a recent study, only 11% of patients with cirrhosis showed 
an increase in reflectivity, while this abnormality was detected in 50% of patients with fatty 
livers, 42% of patients with minimal change livers and 33% of normal livers (The Clinical 
NMR Group, 1987). In another recent investigation, the sensitivity of ultrasonography in 
cirrhosis, fatty change, chronic active hepatitis and chronic persistent hepatitis was 68%, 
55%, 41% and 31%. It should be noted that ancillary signs of portal hypertension were 
used to support a diagnosis of cirrhosis (Celle et al., 1988). 
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Some workers have indicated that it is possible to distinguish between hepatic fibrosis and 
fatty change on ultrasonography (Saverymuttu et al., 1986). This has not been the ex-
perience of other workers (Celle et al., 1988; Sandford et al., 1985; The Clinical NMR 
Group, 1987), who have also expressed the view that ultrasonography is not a useful 
screening investigation for parenchymal liver disease. Our approach, which was to deter-
mine only if evidence of diffuse disease was present, is supported by these findings. It was 
argued that if an abnormal scan was encountered during screening, the patient could be 
evaluated further by liver biopsy because ultrasonography would not enable us to deter-
mine which of the various causes of diffuse liver disease encountered in this institution was 
present. 
In contrast, the sensitivity of both ultrasonography and scintigraphy in the detection of fo-
cal liver disease was much higher (88% and 92% respectively); the corresponding values 
for accuracy of a negative test were also higher (88% and 94% respectively). In the 
analysis of published reports, the sensitivity of the 2 procedures was 72% and 87% respec-
tively, and the accuracy of a negative 67% and 86% respectively. The specificity of both 
tests in our study were high, 96% and 91% respectively. This data indicates that both im-
aging modalities are useful in screening for focal liver disease. However, ultrasonography 
is capable of providing information on morphology and, as such, can aid in establishing a 
cause of the focal disease. 
However, although ultrasonography was found to have a high accuracy in the detection of 
space-occupying lesions in the present study, overlap between the ultrasonographic fea-
tures of amoebic liver abscess, hepatocellular carcinoma and metastatic carcinoma 
resulted in a correct final diagnosis being made in only 81% of patients with amoebic liver 
abscess, 29% with hepatocellular carcinoma and 43% of patients with metastatic car-
cinoma who had undergone ultrasonography. The observation that the 2 senior 
radiologists differed in their interpretation of 72 (33%) of the 217 ultrasound scans of 
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patients with focal liver disease in whom they had both correctly detected the presence of 
space-occupying lesions, lends support to the fact that the amount of overlap between the 
ultrasonographic features of amoebic liver abscess, hepatocellular carcinoma and metas-
tatic carcinoma, which are common causes of liver disease in this environment (Maharaj 
et al., 1986a), is fairly substantial. This contention is further supported by data arising from 
analysis of published reports which describe the ultrasonographic appearances of these 
diseases. Studies on the ultrasonographic morphology of hepatocellular carcinoma and 
amoebic liver abscess in patients at this institution indicated that lesions may be multiple 
(43% and 25% respectively), echogenic (67% and 1% respectively), occur in the left lobe 
(43% and 17% respectively) and have a smooth (10% and 68% respectively) or irregular 
edge (90% and 32% respectively) in both diseases (Boultbee, 1979; Boultbee et al., 1979). 
In a subsequent investigation, 13% of amoebic liver abscesses were noted to be 
echogenic (Simjee et al., 1985). Hypoechoic lesions may also occur in both conditions; 
this abnormality was detected in 84% of patients with amoebic liver abscess (Boultbee et 
al., 1979) and 23% of patients with hepatocellular carcinoma (Maringhini et al., 1988). 
Thus, it is possible that each disease may mimic the other in certain patients. This has 
been found to be the case; in the paper on amoebic liver abscess (Boultbee et al., 1979) it 
was reported that in 3 patients, amoebic liver abscess was incorrectly diagnosed as a 
hepatic tumour and that in 2 patients, the latter disease was wrongly diagnosed as 
amoebic liver abscess during ultrasonography. In addition, Boultbee recorded that one 
patient with hepatocellular carcinoma, which had a smooth edge on ultrasonography, was 
aspirated and 400 ml of "pus" obtained (Boultbee, 1979), while Barnes and co-workers en-
countered a patient with amoebic liver abscess in whom the ultrasound scan was misin-
terpreted as demonstrating a hepatic tumour (Barnes et al, 1987). Greater awareness of 
this diagnostic problem among both radiologists who perform ultrasonography and doc-
tors who are responsible for the care of patients is needed, especially since the clinical 
presentation of these 2 diseases is often similar viz. right upper quadrant pain and tender 
hepatomegaly. In contrast, it is generally accepted that the ultrasonographic appearance 
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of pyogenic liver abscess, an uncommon condition in this environment, is non-specific and 
varies from anechoic to high echogenic lesions, and that, although some ultrasonographic 
features of pyogenic liver abscess differ from those of amoebic liver abscess, these dis-
eases cannot be distinguished from each other on the basis of ultrasonography alone 
(Kuligowska et al., 1982; Ralls et al., 1987). 
The highly variable ultrasonographic appearances of hepatocellular carcinoma and metas-
tatic carcinoma may also make it difficult to distinguish one disease from the other; 
metastatic carcinoma may be solitary, multiple, echogenic, hypoechoic, totally echo-free, 
or demonstrate mixed patterns of increased and decreased echogenicity or "bulls-eye" 
(centrally echogenic surrounded by hypoechoic rim) lesions (Green et al., 1977; Scheible 
et al., 1977). When the ultrasonographic morphology in hepatocellular carcinoma was 
compared to that of metastatic carcinoma, it was noted that lesions which were echogenic 
or of mixed echogenicity occurred in both diseases (31% vs 18% and 41% vs 12% 
respectively). In addition, "bulls-eye" lesions were present in both conditions (16% and 
71% respectively) (Wong et al., 1985). Although these workers do not discuss this point, it 
is evident that each disease can simulate the other. This contention is supported in a 
paper on ultrasonography in hepatocellular carcinoma, in which the author stated that in 
some patients, distinction between hepatocellular carcinoma and metastatic malignancy 
proved difficult; the number of patients was not stated (Boultbee, 1979). 
The author is not aware of any publications which suggest that problems in differentiating 
between amoebic liver abscess and metastatic carcinoma may occur. However, on the 
basis of the foregoing information, it is likely that diagnostic difficulties may exist. This was 
found to be the case in the present study; in one patient, amoebic liver abscess was mis-
diagnosed as metastatic carcinoma at ultrasonography, and in another, the opposite oc-
curred. 
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Interobserver differences may influence the results of imaging studies (Conn and Spencer, 
1972; Nishiyama et al., 1975). In the present study, interobserver differences between the 
two senior radiologists were present most frequently when ultrasound scans of patients 
with diffuse liver disease and scintigraphic scans of normal individuals were examined 
(25.5% and 14.5% respectively). The interobserver variation between the initial observer 
and the two senior radiologists was only slightly higher than that between the two senior 
radiologists. It is evident that the possible lack of experience of the registrar-in-training did 
not affect the results of scans substantially. This could be due to the fact that the person 
who initially performs the procedure has access to the request form which provides clinical 
details of the patient being examined. 
Ultrasonography has made important contributions to the detection and management of 
patients with focal liver disease. It is used in the early detection of hepatocellular car-
cinoma in communities which are at risk of developing this tumour (Sheu et al., 1985), and 
in screening for metastatic malignancy in patients with extrahepatic neoplasia (Schreve et 
al., 1984; Smith et al., 1982; Taylor, 1982). It has also simplified the management of un-
complicated and complicated amoebic liver abscess (Berry et al., 1986; Gupta et al., 1987; 
Maharaj et al., 1987b). However, the diagnostic pitfalls that may be encountered as a 
result of an overlap between the features of these space-occupying lesions need to be 
remembered. Accordingly, liver biopsy or aspiration might be required to determine the 
cause of focal disease in selected patients in whom space-occupying lesions are detected 
on ultrasonography. Scintigraphy can also be used to detect space-occupying lesions, 
but information on morphology will not be obtained. On the other hand, neither scintig-
raphy nor ultrasonography is sensitive enough to be used in screening for diffuse liver dis-
ease. In addition, ultrasonography provides little useful or specific information about 
parenchymal liver disease. Therefore, when diffuse parenchymal liver disease is 
suspected, liver biopsy would be needed to determine the presence and nature of the dis-




COMPLICATIONS ASSOCIATED WITH LIVER BIOPSY 
Introduction 
Liver biopsy, an important diagnostic procedure in patients in whom either diffuse or focal 
liver disease is suspected, is associated with complications, the major one being intra-
peritoneal haemorrhage. Liver tissue is usually obtained by percutaneous biopsy, or at 
peritoneoscopy. However, the latter procedure is not widely available in developing 
countries. 
When percutaneous needle biopsy of the liver is carried out, a single specimen is usually 
obtained. It has been shown that the diagnostic yield of liver biopsy is improved when two 
specimens are taken, and can be improved further by taking a third biopsy specimen 
during the procedure (Maharaj et al., 1986b). It appeared that this could be achieved 
without exposing the patient to a greater risk of complications provided that standard 
precautions were taken. Since this study was carried out in a small group of patients, and 
since there was a paucity of data on the frequency and nature of complications that occur 
when 2 or more consecutive biopsy specimens are taken, a retrospective study was con-
ducted to provide further data on the safety of this procedure, as well as that of peritoneo-
scopic biopsy at King Edward VIII Hospital, Durban. 
Patients and Methods 
A list of all patients in whom liver biopsy had been carried out at King Edward VIII Hospital, 
Durban during the period 1984-1987 (inclusive) was obtained from the Department of 
Anatomical Pathology. 
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The clinical records of all patients, other than those admitted to the paediatric wards, were 
examined and a note made of the type of biopsy done, and the presence and nature of 
complications. When percutaneous biopsy had been performed, the number of 
specimens taken during the procedure was also recorded. 
Percutaneous liver biopsies were carried out in the general medical and surgical wards of 
the hospital by interns after consent for the procedure was obtained from the patient. A 
platelet count greater than 100 x 109/l and a prothrombin index greater than 75% was con-
sidered a prerequisite for the performance of this procedure. After infiltration of the skin 
and subcutaneous tissue with 2% lignocaine, the biopsy was performed using a "Tru-Cut" 
needle. Based upon their individual preferences, the doctors would take either 1, 2 or 3 
specimens; the additional specimens were obtained by redirecting the biopsy needle 
through a single entry site (Maharaj et al, 1986b). Thereafter, the nursing staff were re-
quested to monitor the pulse rate and blood pressure. Some interns prescribed an opioid 
analgesic, usually pethidine, before the procedure. Patients were kept in hospital for at 
least 24 hours after biopsy. 
Peritoneoscopy was carried out under local anaesthesia in an operating theatre by 
specialist gastro-enterologists. The precautions described for percutaneous biopsy were 
also taken for peritoneoscopy. After completion of the procedure, the patients were 
returned to their respective general medical or surgical wards, where the nursing staff were 
required to monitor the patients' vital signs. 
Results 
A total of 1525 percutaneous biopsies were carried out during the study period. A single 
specimen was obtained in 484 patients, two specimens in 578 patients and three in 463 
patients. The morbidity and mortality rates associated with this procedure were 2.0% and 
80 
0.3% respectively. The nature and frequency of complications are shown in Table 1e. 
Patients in whom 2 or 3 specimens were obtained did not have a higher incidence of 
fatalities, pain, hypotension or biliary peritonitis, than those in whom a single specimen 
was taken. 
The final diagnosis and number of specimens obtained in the 5 patients who died were as 
follows: hepatocellular carcinoma (n = 2; 1 specimen); Kaposi's sarcoma (n = 1; 3 
specimens); disseminated tuberculosis plus alcoholic hepatitis (n = 1; 3 specimens); pelvic 
and lung abscesses (n = 1; 1 specimen). 
Intraperitoneal bleeding was the cause of death in all patients; hypotension developed 
within 4 hours. Only one patient had been adequately monitored after the procedure. A 
gradual drop in blood pressure had been noted, but was not acted upon until shortly 
before his death. In the other 4 patients, the first blood pressure measurement was made 
when it was apparent that the patient had developed a complication. Resuscitation 
measures were successful in returning the blood pressure to normal in 2 patients. 
However, one patient refused surgery and in the other, there was a delay in the implemen-
tation of a decision made by the surgeons who had been consulted, to do a laparotomy. 
In the other 2 patients, all attempts at restoring the circulating blood volume failed. 
Hypotension, unassociated with death, occurred in 15 patients. Treatment with 
intravenous fluids, freeze-dried plasma and/or blood transfusions restored the blood pres-
sure to normal in all cases. In the 3 patients in whom pain accompanied the hypotension, 
analgesics were also given. Another 15 patients had pain after their biopsy - in only 1 had 
3 specimens been taken. 
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Of the 217 patients in whom peritoneoscopic biopsies were performed, complications 
were encountered in 5 (2.3%); all developed hypotension which responded when 
intravenous fluids, freeze-dried plasma or blood was given. One patient (0.5%), who had 
hepatocellular carcinoma, died as a result of intraperitoneal bleeding. The blood pressure 
had been restored to normal before a decision against surgical intervention to stop bleed-
ing was made because the prognosis was considered to be poor. In all six patients, the 
blood pressure had not been monitored after the procedure. 
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Table 1e. MORBIDITY AND MORTALITY FOLLOWING PERCUTANEOUS LIVER 
BIOPSY WHEN ONE, TWO OR THREE SPECIMENS WERE TAKEN. 
One 
specimen 
























TOTAL 17 11 36 
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Discussion 
Blind percutaneous needle biopsy of the liver is a valuable method of detecting hepatic 
disease in developing countries (Atoba and Junaid, 1980; Maharaj et al., 1986a; 1987a). 
However, important pathology can be overlooked when liver biopsy is performed in the 
conventional manner because of the influence of sampling variability (Abdi et al., 1979; 
Maharaj et al., 1986b). The diagnostic yield of this procedure is improved when two or 
three consecutive biopsy specimens are obtained by introducing the biopsy needle 
through a single entry site and redirecting it by about 20° to 30° from the initial position 
(Maharaj eta!., 1986b). 
The present study in 1525 patients indicates that this can be achieved without an increase 
in morbidity and mortality; patients in whom two or three specimens were taken (578 and 
463 patients, respectively) did not have a higher incidence of fatalities, pain, hypotension, 
or biliary peritonitis than those in whom a single specimen was obtained (484 patients). 
These findings are in agreement with those of an earlier investigation in which 344 patients 
required between 2 and 11 biopsies; an increased frequency of complications, all minor in 
nature, were observed after more than 3 consecutive biopsies were performed (Perrault et 
al., 1978). A similar conclusion was reached by a group of workers who performed mul-
tiple liver biopsies under ultrasonographic guidance on 95 patients with carcinoid and en-
docrine pancreatic tumours (Andersson et al., 1987). The only major complication in this 
study, intrahepatic haematoma, occurred in 3 patients who had required more than three 
biopsies. Thus, it appears that the safety of both blind and imaging-guided needle biopsy 
of the liver is adversely affected by taking more than three consecutive specimens. 
Fifteen (1.0%) patients in this study complained of either abdominal or thoracic pain after 
percutaneous liver biopsy. The incidence of pain in 3 studies involving 288, 1000 and 
68276 patients was 1.4, 4.5, and 1.2% respectively (Atoba and Junaid, 1980; Perrault et al., 
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1978; Piccinino et al., 1986). Pain was usually experienced soon after the biopsy and 
responded to analgesics (Piccinino et al., 1986). In the present study, pain was least fre-
quently noted in patients in whom 3 biopsy specimens were taken. A probable reason for 
this anomaly is that the doctors who obtained 3 specimens during the biopsy made 
greater use of opioid analgesics before the procedure. 
Hypotension developed in 1% (15) of patients in this study. This complication was cor-
rected by the administration of intravenous fluids, freeze-dried plasma or blood. None of 
the patients needed a laparotomy. When pain accompanied the hypotension (3 patients), 
analgesics were also given. Perrault and co-workers encountered hypotension in 2.8% of 
the 1000 patients in their study (Perrault et al., 1978). Hypotension and pain occurred 
together in 14 of their patients and five patients required blood transfusions because of a 
reduction in haemoglobin level of up to 4g/dl. Clinically significant haemorrhage requir-
ing either blood transfusion or laparotomy, or both, was observed in 2.1% of 288 patients 
reviewed by Atoba and Junaid (Atoba and Junaid, 1980) and in 1.5% of 200 patients who 
underwent biopsy as a day-case procedure (Westaby et al., 1980). This complication was 
also encountered in 40 (0.6%) of 6379 patients studied by Sherlock and colleagues 
(Sherlock et al., 1984), in 8 (0.2%) of 4000 patients reported by Hegarty and Williams 
(Hegarty and Williams, 1984), and in 6 (0.5%) of 1174 patients studied by Knauer (Knauer, 
1978). Of the 24 significant complications among 7532 biopsies recorded by Terry, 16 
(0.2%) were due to bleeding (Terry, 1952). In a large multicentre study of 68276 patients, 
haemoperitoneum developed in 16 (0.02%) of patients (Piccinino et al., 1986). 
The mortality rate in the present study was 0.3%; 3 patients who had a single specimen 
and 2 who had 3 specimens taken during the biopsy, died as a result of the procedure. 
The cause of death in all five patients was intraperitoneal bleeding. There were 5 (1.7%) 
deaths among the 288 patients reviewed by Atoba and Junaid, 3 were due to haemorrhage 
(Atoba and Junaid, 1980). There were no fatalities in 3 studies of 1174 (Knauer, 1978), 
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1000 (Perrault et al., 1978), and 200 patients (Westaby et al., 1980) respectively. The mor-
tality rate in two early large series of 10600 (Terry, 1952) and 20016 (Zamcheck and 
Klausenstock, 1953) patients was 0.12% and 0.17% respectively. More recently, a review 
of 79381 biopsies has given a figure of 0.015% (Lindner, 1967). Haemorrhage was the 
major cause of mortality in these studies. There were 2 fatalities in the group studied by 
Sherlock and co-workers (Sherlock et al., 1984), and one in the series reported by Hegarty 
and Williams (Hegarty and Williams, 1984), yielding a mortality rate of 0.03% for both 
groups. Bleeding was the cause of death in the latter patient. The mortality rate in the 
recent large multicentre study of 68276 patients was 0.009%; all six fatalities were due to 
haemoperitoneum (Piccinino et al., 1986). 
Biliary peritonitis developed in one (0.07%) of the 1525 patients studied. This patient re-
quired a laparotomy. The incidence of this complication in the series reported by Terry in 
1952 and by Piccinino and others in 1986 was 0.09% and 0.02% respectively. 
The morbidity and mortality rates in the 217 patients who were subjected to peritoneo-
scopic biopsies were 2.3% and 0.5% respectively; 5 patients developed hypotension 
which responded to treatment with intravenous fluids, freeze-dried plasma or blood trans-
fusion, and one patient died as a result of intraperitoneal bleeding. A review of 917 
peritoneoscope biopsies revealed that 1 (0.1%) fatality occurred; haemorrhage was the 
cause of death (De Groen et al., 1987). In addition, 4 (0.4%) patients developed bleeding 
which required intravenous fluids or blood transfusions. No complications or deaths were 
recorded in 2 studies of 250 (Hall et al., 1980) and 102 (Rattan et al., 1987) peritoneo-
scope biopsies. The only complication that was attributed to the liver biopsy in a study of 
238 patients who had peritoneoscopy was bile leakage (Barry et al., 1978). This was dis-
covered incidentally at laparotomy in one patient. In a prospective study of 603 
peritoneoscopies, haemorrhage from the biopsy site and death (due to this complication) 
occurred in 6 (1%) and 2 (0.3%) patients, respectively (Kane and Krejs, 1984). A report 
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on 415 peritoneoscopic and 92 percutaneous biopsies indicated that the only major com-
plication, intrahepatic haemorrhage, developed in one patient (Celle et al., 1988). 
However, the type of biopsy carried out in this patient was not mentioned. Reynolds and 
Cowan have recorded their experience with 2400 peritoneoscopies (Reynolds and Cowan, 
1985). Two patients with hepatocellular carcinoma died after bleeding from the liver 
biopsy site. The mortality rate associated with peritoneoscopic biopsy cannot be calcu-
lated because the number of patients who had a biopsy during the examination is not 
given. 
The mortality rate from both percutaneous and peritoneoscopic liver biopsies in the 
present study is high. Four of the 6 patients who died had malignant disease; 3 had 
hepatocellular carcinoma and one Kaposi's sarcoma. Although it could be argued that 
the prognosis in these patients was extremely poor (Kew and Geddes, 1982), a critical 
evaluation of the factors that could have predisposed to their deaths is essential because it 
could yield important information which might help in preventing serious complications in 
other patients having a liver biopsy. Haemoperitoneum was the cause of death in all 
patients. None had a contraindication to the biopsy (Losowsky, 1982). A platelet count 
greater than 100 x 109/l and a prothrombin index greater than 75% was present in all 
patients in this study, including those who died and those who developed hypotension; 
bleeding occurred despite taking these precautions. It is generally accepted that there is 
an increased risk of bleeding in patients who are deficient in clotting factors or have throm-
bocytopaenia (Milward-Sadler and Whorwell, 1985; Sherlock, 1985). However, a number 
of authors have stated that haemorrhage is usually a random event which cannot be pre-
dicted with methods that are currently available (Ewe, 1981; McGili, 1981), and that it 
usually develops when least expected, and when, at the time of biopsy, the risk seemed 
small (Sherlock, 1985). Therefore, doctors need to be prepared for the possible develop-
ment of bleeding in all patients who are subjected to liver biopsy, even those who have no 
87 
contraindications, or are not considered to be at "high-risk" for bleeding. In some institu-
tions two units of blood are routinely available before the procedure (Milward-Sadler and 
Whorwell, 1985). This has not been the practice in our hospital. 
Although there is no data confirming this hypothesis, available evidence suggests that 
there could be an increased risk of bleeding after liver biopsy in patients with hepatocel-
lular carcinoma. Piccinino and colleagues reported that haemoperitoneum was more fre-
quent in patients with neoplastic disease; the nature of these tumours was not mentioned 
(Piccinino et al., 1986). In addition, it is known that hepatocellular carcinoma may rupture 
spontaneously or following trauma, resulting in an acute haemoperitoneum which neces-
sitates an emergency laparotomy (Chen et al., 1988; Maraj et al., 1988). Accordingly, it is 
possible that needle puncture during biopsy may precipitate rupture of the tumour. 
The "Tru-Cut" needle was used for all percutaneous liver biopsies in the present study. 
Some workers have observed an increased incidence of serious complications and death 
after biopsy with the "Tru-Cut" needle (Piccinino et al., 1986), while others have not found 
this to be the case (Perrault et al., 1978). The incidence of haemorrhage and deaths in a 
study of 4000 patients who were biopsied with a "Tru-Cut" needle (Hegarty and Williams, 
1984) was not higher than that reported in a group of 6379 patients in whom the Menghini 
needle was used (Sherlock et al., 1984). In studies that have compared the yield of 'Tru-
Cut" and Menghini needle biopsies in patients with cirrhosis, a frequent cause of un-
explained hepatomegaly in developing countries (Atoba and Junaid, 1980; Bahl et al., 
1975; Maharaj et al., 1986a; Patel and Lwanga, 1971), the "Tru-Cut" biopsies were found to 
be longer, less fragmented and superior for the diagnosis of this disease (Colombo et al., 
1988; Vargas-Tank et al., 1985). 
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Hypotension developed within 4 hours in all patients who died. Only one patient had been 
adequately monitored after liver biopsy; a gradual reduction in blood pressure had been 
detected, but no remedial measures were instituted until shortly before his death. In the 
other patients, the first blood pressure measurement was made when it was apparent that 
a complication had occurred. A similar observation was made in the 5 patients who 
developed hypotension after peritoneoscopic biopsy. Examination of the case records of 
all patients in this study revealed that in the majority of patients, the after-care and monitor-
ing were either inadequate or non-existent. This important duty in our hospital is 
delegated to nurses, who are already overcommited as a result of staff shortages and 
overcrowding of wards. In order to reduce the mortality associated with liver biopsy, the 
doctor who carries out a percutaneous biopsy or requests a peritoneoscopic biopsy will 
need to assume responsibility for monitoring the patient, for at least the first 4 hours after 
the biopsy - the period during which most of the serious complications are likely to be-
come manifest (Perrault et al., 1978; Piccinino et al., 1986). This will ensure that resuscita-
tion and other appropriate measures will be instituted timeously. Further, though less fre-
quent, observations should be made over the next 18 hours because some patients may 
show signs of complications during this period (Piccinino et al., 1986; Sherlock, 1985). It 
is noteworthy that a marked increase in blood pressure has been recorded very early after 
biopsy in some patients with haemorrhage (Middleton et al., 1977). It is generally ac-
cepted that successful needle biopsy of the liver without complications demands good 
technique (Hegarty and Williams, 1984; Milward-Sadler and Whorwell, 1985; Sherlock, 
1985; Zamcheck and Klausenstock, 1953). Accordingly, interns must always be ade-
quately trained. 
Piccinino and colleagues stated that the retrospective nature of their study allowed an ac-
curate evaluation only in patients developing very serious complications; the number of 
patients developing minor or asymptomatic complications could be larger (Piccinino et al., 
1986). Their comments are also applicable to the present study. 
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Blind percutaneous needle biopsy of the liver is an important and valuable method for 
detecting liver disease in developing countries, especially those in which facilities for 
hepatic imaging and peritoneoscopy are not widely available (Atoba and Junaid, 1980; 
Maharaj et al., 1986a). A trained operator should perform the procedure and two 
specimens should be taken (Maharaj et al., 1987a) by redirecting the needle through a 
single entry site as this improves the diagnostic yield of the biopsy (Maharaj et al., 1986b) 
without increasing the risk of complications. Greater awareness of the hazards of liver 
biopsy and their prevention is needed; good technique, careful monitoring, and prompt 




TRU-CUT' NEEDLE BIOPSY OF THE LIVER: IMPORTANCE OF THE 
CORRECT TECHNIQUE 
Introduction 
Percutaneous needle biopsy of the liver is a useful method for detecting the presence and 
nature of hepatic disease. The specimens obtained need to be of an adequate length for 
histological diagnosis because pathology is often missed due to the small size of the 
sample (Sherlock, 1985). 
The 'Tru-Cut" needle (Travenoi Laboratories, Deerfield, USA) is used for this purpose at 
King Edward VIII Hospital, Durban. The author recently discovered that the technique that 
he had been using for liver biopsy was a modification of the one recommended by the 
manufacturer for breast biopsy (Travenoi Laboratories, 1980), and that the method sug-
gested by them (Travenoi Laboratories, 1980) was one of two he had discouraged col-
leagues from using because the length of specimens obtained was inadequate. 
In view of the importance of the length of the liver tissue specimen submitted for histologi-
cal examination, a study comparing the three techniques was conducted in cadavers. 
Patients and Methods 
"Tru-Cut" Biopsy Techniques 
The 'Tru-Cut" needle consists of an inner solid needle, the obturator and an outer hollow 
needle, the cannula. The obturator has a pointed end for tissue penetration and immediat-
ley behind this is a notch for the biopsy specimen. The cannula serves as a cutting 
sheath. 
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The manufacturers of the "Tru-Cut" needle recommend one technique for what they term 
"usual biopsy procedures" and another for breast biopsy (Travenol Laboratories, 1980). In 
both cases, preparation of the biopsy site, adequate anaesthesia and incision of the skin 
with a scalpel is advised. The latter step is necessary because the needle is not designed 
to puncture the skin. 
Thereafter, if a breast biopsy is desired, the obturator is retracted fully to cover the 
specimen notch (i.e. the needle is closed), the T-shaped cannula handle is held firmly while 
the device is inserted up to the tissue to be biopsied, and the obturator advanced as far as 
possible. Finally, the obturator is held firmly to stabilise the assembly, the cannula handle 
(outer sheath) is advanced to cut the tissue which has prolapsed into the specimen notch, 
and the device withdrawn (Technique 1) (Figure 1). 
For the usual biopsy procedures, the manufacturer recommends that with the obturator 
fully retracted and held firm, the needle is inserted into the tissue being biopsied, the can-
nula is retracted (to expose the specimen notch) and then advanced (to cut the tissue 
which has prolapsed into the specimen notch), and the assembly withdrawn (Technique 2) 
(Figure 2). Another possible technique involves inserting the closed needle into the liver 
and advancing and then retracting the obturator (Technique 3) (Figure 3). 
In the present study, one modification was made to the breast biopsy technique - the 
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Schematic representation of an "alternative" 























Twenty adults who had died of non-natural causes were studied after the liver had been 
exposed at autopsy and found to be normal macroscopically. Each liver was biopsied 
four times, under direct vision, using one "Tru-Cut" needle. The modified breast biopsy 
technique (technique 1) either preceded or followed technique 3 in a random manner. 
Thereafter, the biopsies were repeated using the alternative sequence. All biopsies were 
carried out by a single operator. The length of the specimens was measured immediately 
after each biopsy, and after they had been immersed in formalin. The latter step was 
taken to determine if fragmentation of the specimens occurred with either technique. 
Technique 1 was compared to technique 2 in a similar manner in 10 livers. These 
specimens were not placed in formalin. 
Results 
The results are presented in Tables 1f and 2f. 
The mean length of the liver biopsy specimens that were obtained using the modified 
breast biospy technique was 16.3mm (range: 8-20mm). The corresponding figures for 
technique 3 were 2.7mm (range: 0.5-8mm). Three of the 40 specimens (7.5%) obtained 
using the latter technique fragmented when placed in formalin; this did not occur in any of 
the 40 specimens taken using the alternative method (Table 1f). The average length of 
specimens using technique 2 was 7.7mm (Table 2f). 
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TABLE 1f. LENGTH OF LIVER BIOPSY SPECIMENS OBTAINED WITH A "TRU-
CUT" NEEDLE USING TECHNIQUE 1 AND 3. 
Patient 
No. 
























First biopsy Second biopsy 
18 (17) 20 (19) 
20 (20) 15 (15) 
19 (19) 8 (8) 
16 (16) 13 (12) 
13 (12) 12 (12) 
13 (12) 12 (11) 
20 (20) 16 (15) 
20 (20) 10 (10) 
13 (12) 14 (13) 
10 (10) 14 (14) 
8 (7) 11 (11) 
20 (20) 12 (12) 
20 (20) 20 (20) 
20 (20) 14 (14) 
20 (20) 11 (11) 
15 (15) 20 (20) 
17 (17) 20 (20) 
19 (19) 18 (18) 
20 (20) 16 (16) 
20 (20) 18 (18) 
17.1 (16.8) 14.7 (14.5) 




























































































figures in brackets indicate the length of specimens after immersion in formalin, 
indicates fragmented specimen. 
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TABLE 2f. LENGTH OF LIVER BIOPSY SPECIMENS OBTAINED WITH A "TRU-
CUT' NEEDLE USING TECHNIQUE 1 AND 2. 
Patient LENGTH OF SPECIMENS (MILLIMETRES) 
No. 
Technique 1 Technique 2 































































The diagnostic yield of percutaneous needle biopsy of the liver is influenced by the length 
of the specimen (Sherlock, 1985); diagnostic accuracy improves as increasing amounts of 
tissue become available for histological examination (Holund et al., 1980). 
The present investigation indicates that, when the "Tru-Cut" needle is used for liver biopsy, 
the modified breast biopsy technique should be used, because the specimens obtained 
were much longer and adequate for histological diagnosis; the average length was 
16.3mm. The shortest specimen obtained measured 8mm and none of the specimens was 
fragmented. This data lends support to the recommendation of a number of workers that 
this technique should be used for liver biopsy (Hegarty and Williams, 1984; Walters and 
Paton, 1980). 
However, the limitations of the alternative methods, including that recommended by the 
manufacturer (Travenol Laboratories, 1980), have not been emphasised in the literature. 
The average length of specimens obtained with technique 2 (cannula retracted and ad-
vanced) and technique 3 (obturator advanced and retracted) was 7.7mm and 2.7mm 
respectively. The longest specimen obtained with technique 3 measured 8mm. In addi-
tion, 7.5% of specimens were fragmented. 
It is not only diagnostic accuracy of the procedure that is compromised by poor tech-
nique, but also safety. Hegarty and Williams have stated that successful liver biopsy 
without complications demands good technique and that inadequate specimens and 
serious complications are the hallmarks of the inexperienced operator (Hegarty and Wil-
liams, 1984). Thus, the importance of the correct technique during needle biopsy of the 
liver cannot be stressed enough, especially in developing countries where the procedure is 





The causes of hepatomegaly at King Edward VIII Hospital, Durban: A prospective 
study of 240 black patients. 
In this prospective study of 240 black patients with liver enlargement admitted to the medi-
cal wards of King Edward VIII Hospital, Durban, a cause for the hepatomegaly was found 
in 92.5% of patients (63.8% without recourse to biopsy, 28.7% after liver biopsy). The 
commonest cause was congestive heart failure (36.7%), followed by amoebic liver 
abscess (7.1%), hepatocellular carcinoma (5.8%) and cirrhosis (5.4%). 
Liver biopsy provided the diagnosis in 90.8% of patients with initial unexplained 
hepatomegaly. It appeared that the diagnostic yield of liver biopsy could be increased by 
submitting 3 biopsy specimens for histological examination without increasing the risk of 
complications. 
Hepatic tuberculosis was present in 9.2% of patients who underwent biopsy. There were 
no consistent clinical findings in these patients. Therefore, in communities in which tuber-
culosis is endemic, all patients with unexplained hepatomegaly require liver biopsy since it 
provides the only means of making this diagnosis. 
Sampling variability and its influence on the diagnostic yield of percutaneous needle 
biopsy of the liver. 
In an investigation to determine the influence of sampling variability on the diagnostic yield 
of liver biopsy, 3 consecutive samples were obtained from each of 75 patients by redirect-
ing the biopsy needle through a single entry site. In 14.7% of patients all 3 specimens 
were normal, and in 36% there were similar abnormalities in all 3 specimens. In the other 
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patients, sampling variability between specimens was present. In those patients with cir-
rhosis, hepatocellular carcinoma, metastatic carcinoma, or hepatic granulomas the his-
tological abnormality was present in all 3 biopsy specimens in only 50%, 54.5%, 50%, and 
18.8% of patients respectively. No complications were recorded. These findings show 
that important pathology can be overlooked if only a single biopsy specimen is taken, and 
that the method of obtaining 3 consecutive specimens improves the diagnostic yield of 
liver biopsy without an associated increase in complications. 
A prospective study of hepatic tuberculosis in 41 black patients. 
Forty-one black patients aged 21 to 75 years with hepatic tuberculosis diagnosed at liver 
biopsy were studied prospectively. The liver varied in size and consistency and was 
tender in 44 per cent of patients. Abdominal symptoms, weight loss, pyrexia, 
hepatomegaly, splenomegaly and anaemia were absent in 54, 39, 37, 5, 68 and 27 per 
cent of patients respectively. Twenty-two percent of chest radiographs were normal. 
Liver function tests were of little diagnostic value and hepatic imaging techniques often 
gave normal results. Acid-fast bacilli, caseation and co-existent liver disease were 
detected in 59, 51 and 37 per cent of patients respectively. 
Since there is no consistent clinical pattern, a high index of suspicion is necessary if this 
disease is to be detected in communities in which tuberculosis is endemic. In patients 
with unexplained hepatomegaly or hepatosplenomegaly, and patients with pyrexia of un-
known origin, liver biopsy provides the only means of making this diagnosis. 
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The role of ultrasonography and scintigraphy in detecting focal and diffuse liver dis-
ease in developing countries. 
In a study conducted to determine the value of hepatic ultrasonography and scintigraphy 
in detecting liver disease, a total of 425 ultrasound scans and 304 scintigraphic scans of 
patients who had either focal or diffuse liver disease, or who had normal livers were 
reviewed by two senior radiologists who worked independently of each other, and who 
were unaware of the patients' clinical details, results of investigations or final diagnosis. 
The accuracy of both ultrasonography and scintigraphy in distinguishing between normal 
and diseased livers was low (68% and 74% respectively). Both techniques performed bet-
ter at detecting focal than diffuse liver disease; the sensitivity of ultrasonography and scin-
tigraphy in focal and diffuse disease were 88% and 92%, and 27% and 54% respectively. 
The specificity of both procedures was high for both types of liver disease (range 91-96%). 
Overlap between the ultrasonographic features of amoebic liver abscess, hepatocellular 
carcinoma and metastatic carcinoma resulted in a correct final diagnosis being made in 
only 81 % of patients with amoebic liver abscess, 29% with hepatocellular carcinoma and 
43% of patients with metastatic carcinoma who had an ultrasound scan. 
The sensitivity of ultrasonography and scintigraphy in detecting cirrhosis (diffuse liver dis-
ease) in patients in whom hepatocellular carcinoma and cirrhosis co-existed was 41% and 
67% respectively. Inter-observer differences between the senior radiologists were present 
in 25.5% of ultrasound scans and 11% of scintigraphic scans of patients with diffuse liver 
disease, 8.8% and 5.7% of scans of patients with focal disease, and 7.9% and 14.5% of 
scans of patients with normal livers respectively. 
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This study indicates that these techniques were neither accurate in detecting diffuse liver 
disease nor capable of determining the cause of diffuse liver disease. Therefore, when dif-
fuse parenchymal liver disease is suspected, liver biopsy would be needed to determine 
the presence and nature of the disease. Although the accuracy of both imaging modalities 
in detecting focal disease is high, overlap between the ultrasonographic features of the 
common causes of space-occupying lesions may result in an incorrect final diagnosis 
being made in certain patients. Accordingly, liver biopsy or aspiration might be required to 
determine the cause of focal disease in selected patients with space-occupying lesions on 
hepatic imaging studies. 
Complications associated with liver biopsy 
In order to determine the frequency and nature of complications associated with per-
cutaneous and peritoneoscopic liver biopsies at King Edward VIII Hospital, Durban, 
patients in whom these procedures had been performed during the period 1984 - 1987 
(inclusive) were studied. A total of 1525 percutaneous biopsies were carried out; a single 
specimen was obtained during the procedure in 484 patients, 2 consecutive specimens in 
578 patients and 3 in 463 patients. The morbidity and mortality rates after percutaneous 
biopsy were 2.0 and 0.3% respectively; pain occurred in 15 patients, hypotension in 15 
patients, and biliary peritonitis in 1 patient. The final diagnoses in the 5 patients who died 
were hepatocellular carcinoma (n = 2), Kaposi's sarcoma (n = 1), disseminated tuberculosis 
plus alcoholic hepatitis (n = 1), pelvic and lung abscesses (n = 1). Intraperitoneal bleeding 
was the cause of death in all patients. Patients in whom 2 or 3 specimens were obtained 
did not have a higher incidence of fatalities, pain, hypotension or biliary peritonitis. 
Of the 217 patients in whom peritoneoscopic biopsies were performed, complications 
were encountered in 5 (2.3%); all developed hypotension. One patient (0.5%), who had 
hepatocellular carcinoma, died as a result of intraperitoneal bleeding. 
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All, except one, of the patients who died, and many patients who had developed hypoten-
sion, had not been adequately monitored. In the majority of patients who underwent both 
types of biopsy, after-care was either inadequate or non-existent. 
This study demonstrates that by taking 2 or 3 consecutive specimens during percutaneous 
liver biopsy an increase in diagnostic yield is achieved without an increase in fatalities and 
complications, that the mortality and morbidity associated with percutaneous and 
peritoneoscopic biopsies are high, and that greater awareness of the hazards of biopsy 
and their prevention is needed; good technique, careful monitoring and prompt and ag-
gressive resuscitation are essential if the mortality rate is to be reduced. 
"Tru-Cut" needle biopsy of the liver: importance of the correct technique. 
In order to determine which technique would provide adequate tissue for histological ex-
amination when the "Tru-Cut" needle is used for liver biopsy, the livers of cadavers were 
biopsied by a single operator, under direct vision, using a 'Tru-Cut" needle. The modified 
breast biopsy technique either preceded or followed one of two alternative methods, one 
of which was recommended by the manufacturer, in a random manner. Thereafter, the 
biopsies were repeated using the alternative sequence. 
The mean length of the liver biopsy specimens that were obtained using the modified 
breast biospy technique was 16.3 mm (range: 8-20mm). The corresponding figures for the 
manufacturer's method were 7.7 mm (range: 2-14mm), and for the third technique were 
2.7 mm (range: 0.5-8mm). Three of the 40 specimens (7.5%) obtained using the latter 
technique fragmented when placed in formalin; this did not occur in any of the 40 
specimens taken using the alternative method. 
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This investigation indicates that the modified breast biopsy technique should be used 
when 'Tru-Cut" needle biopsy of the liver is performed. This provides specimens which are 
adequate for histological diagnosis. In addition, the safety of liver biopsy, which is com-
promised by poor technique, is improved. The alternative methods, including that recom-




CONCLUSIONS AND RECOMMENDATIONS 
In developing countries, a cause for liver enlargement should be sought in all patients in 
whom hepatomegaly is detected, including those in whom liver enlargement is incidental 
to the condition for which hospital admission is required. In the majority of patients, this is 
achieved by careful clinical examination, the appropriate use of laboratory or radiological 
investigations, and where applicable, evaluation of response to appropriate therapy. The 
remaining patients with unexplained hepatomegaly will require liver biopsy to determine 
the cause. Diseases which could otherwise go undetected, such as hepatic tuberculosis, 
are diagnosed when this approach is used. 
Hepatic tuberculosis has a highly variable clinical picture; there are no characteristic find-
ings. A high index of suspicion is needed and liver biopsy is essential in patients with un-
explained hepatomegaly or hepatosplenomegaly, and patients with pyrexia of unknown 
origin as it provides the only means of making this diagnosis. 
The following limitations of liver function tests need to be considered when interpreting the 
results of this investigation in patients suspected of having liver disease, firstly, the 
presence of normal liver function tests does not exclude liver pathology. Secondly, with 
few exceptions, liver function tests are of little diagnostic value; they have a limited 
capacity for differential diagnosis. 
Hepatic imaging studies also have limitations. Neither hepatic ultrasonography nor scin-
tigraphy is useful in detecting or determining the cause of diffuse parenchymal liver dis-
ease; liver biopsy has to be used for this purpose. In addition, although both imaging 
modalities have a high accuracy in detecting focal liver disease, space-occupying lesions 
will not always be detected. Also, overlap between the ultrasonographic features of 
amoebic liver abscess, hepatocellular carcinoma and metastatic carcinoma will result in an 
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incorrect final diagnosis being made in a number of patients. Accordingly, liver biopsy or 
aspiration is required to determine the cause of focal liver disease in selected patients in 
whom space-occupying lesions are detected during hepatic imaging studies. 
Liver biopsy is a valuable method for detecting the presence and nature of liver disease. 
The diagnostic yield of percutaneous liver biopsy is increased by obtaining two (or three) 
consecutive specimens for histological examination by redirecting the biopsy needle 
through a single entry site. This benefit is achieved without an increase in fatalities or com-
plications. However, the overall morbidity and mortality rate in patients undergoing per-
cutaneous or peritoneoscopic biopsy is high. Complications are not detected early be-
cause the after-care in the majority of patients is either non-existent or inadequate. The 
mortality rate will be reduced when doctors assume responsibility for monitoring patients; 
complications will be detected early, and resuscitation and other measures will be in-
stituted timeously. 
When the "Tru-Cut" needle is used incorrectly, the tissue specimens obtained are inade-
quate for histological diagnosis and the risk of serious complications is increased. Ac-
cordingly, greater emphasis on good technique and adequate training of operators is 
needed. 
It is against this background that the following recommendations on percutaneous liver 
biopsy are made. 
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RECOMMENDATIONS ON PERCUTANEOUS "TRU-CUT" NEEDLE BIOPSY OF THE 
LIVER IN DEVELOPING COUNTRIES. 
Precautions 
1. A skilled operator is required: 
a. The technique is first taught on 500g margarine which has just been 
removed from a freezer. 
b. A number of "biopsies" can be done until both the teacher and operator 
are satisfied (The incorrect technique should also be demonstrated by the 
teacher to show the inadequacy of the sample obtained). 
c. Further practice can be obtained in the necropsy room, if required. 
d. Thereafter, the operator watches the procedure being carried out in a 
patient, performs the biopsy under supervision, and finally, does so on his 
own. 
2. The prothrombin time must be checked. 
a. If the prothrombin time is prolonged more than 3 seconds over control 
values, biopsy should be postponed and vitamin K 10mg given intramus-
cularly for a few days. 
b. If the prothrombin time remains prolonged despite vitamin K, and biopsy 
is considered essential, fresh frozen plasma should be given (one unit 
before, one during, and one after the biopsy). 
c. If the prothrombin time is prolonged more than 6 seconds, then the pro-
cedure should not be carried out. 
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3. The platelet count must be checked. 
a. A platelet count greater than 100 x 109/l has been recommended, but in 
recent years, the minimum has, by general agreement, been reduced to 
80X109/!. 
b. If the platelet count is reduced below this level, and biopsy is considered 
essential, platelet concentrates may be used. The bleeding time must be 
checked in these patients both before and after the platelet transfusion. 
4. Blood should be available. 
a. Two units of blood should be cross-matched before the procedure. 
b. An intravenous cannula should be placed in-situ. 
5. The path to the liver should be normal. 
a. If there is skin or chest infection, biopsy should be postponed. 
b. When ascites is appreciable, it should be treated first because ascites 
causes the liver to float away from an advancing needle. 
6. The day of the week and time of biopsy should be carefully chosen. 
In the interests of safety, biopsies should not be carried out: 
a. After 11 hOO. 
b. On weekends. 
c. When the ward is "on-intake". 
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Procedure 
The correct procedure should be used. 
1. Preparation 
a. The patient should lie flat on the edge of the bed with the right hand 
placed behind the head. 
b. Except when it is necessary to biopsy a specific area, the intercostal route 
should be used. 
c. The site for biopsy is selected by craniocaudal percussion over the chest 
in the mid-axillary line until an intercostal space is reached where dullness 
is maximal at the end of expiration. The intercostal space below this is 
used. This usually involves traversing either the eight, ninth or tenth inter-
costal space. 
2. Technique 
a. The skin is cleansed with a suitable antiseptic. 
b. 10 ml of 2% lignocaine is drawn up and infiltrated first subcutaneously, 
then into the intercostal area, and finally down to the diaphragm and cap-
sule of the liver. Care must be taken to infiltrate each area adequately. 
c. The patient is trained to take several deep breaths in and out and to hold 
his breath in deep expiration for a long as he can. 
d. A small incision is made in the skin with a scalpel-blade to facilitate entry 
of the biopsy needle. 
e. With the patient breathing quietly, the needle is introduced and advanced 
until it is felt to give into the space overlying the liver. 
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f. The patient is told to breathe out and then stop breathing, and the biopsy 
is completed as follows. 
i. The 'Tru-Cut" needle, which is in a closed position, is advanced 
2-3cm into the liver, 
ii. With the outer cutting sheath (cannula) held still, the obturator 
(inner trocar) is advanced, 
iii. The obturator is then held steady, while the outer cutting sheath is 
advanced, 
iv. The whole needle is withdrawn quickly. 
Steps i to iii consist of 3 forward movements (see the figure) 
The entire maneouvre (step f) should take less than 3 seconds. 
g. The biopsy specimen is removed from the notch and placed in formalin. 
h. A second specimen is taken by reintroducing the needle through the 
same entry site and redirecting it by about 20° to 30° from the original 
position. Steps f and g are then repeated. 
i. The skin incision is covered with plaster. 
After-Care 
1. The patient is asked to lie on his right side for 4 hours. 
2. The patient is advised to rest in bed for 24 hours. 
3. The doctor who performs the biopsy must assume responsibility for monitoring 
the patient for haemorrhage and other serious complications during the first 6 
hours after the procedure. Blood pressure and pulse rate must be measured im-
mediately after the biopsy, at 15 minute intervals for the first 2 hours, at 30 minute 
intervals for the next 2 hours, and at hourly intervals for the next two hours. 
4. The nursing staff can be requested to assist with further observations. 
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Awareness of complications 
1. The mortality rate after percutaneous liver biopsy is high. 
2. Death is usually a result of haemorrhage into the peritoneum. 
3. Strict observations should give an early indication of bleeding, and if blood trans-
fusion fails to stabilise the situation, laparotomy has to be considered. 
4. Adherence to the measures outlined above, prompt and aggressive resuscitation 
and early involvement of surgeons in the management of serious complications 
will reduce the mortality rate. 
5. The complications that may be encountered after biopsy include pain, haemor-
rhage, biliary peritonitis, haemothorax, pneumothorax, perforation of the colon or 
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These conclusions and recommendations are based upon information which is presented 
in the foregoing chapters. In addition, during the preparation of recommendations on per-
cutaneous liver biopsy, a number of papers which were relevant to the topic were con-
sulted (Hegarty and Williams, 1984; Losowsky, 1982; Millward-Sadler and Whorwell, 1985; 
Sherlock, 1985; Walters and Paton, 1980). 
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